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Ageing is associated with a loss of muscle mass, a processes known as “sarcopenia”. It 
has been postulated that one of the reasons underlying this muscle loss is a decreased 
ability to repair itself in response to damage. Repair of muscle is facilitated by a specific 
population of progenitor adult stem cells known as satellite cells in situ and myoblasts 
ex vivo. The work in this thesis has used a cell culture approach to study the behaviour 
of human myoblasts and compare the inherent effects of age (by studying myoblasts 
taken from young and old people) and using an in vitro model of ageing, (i.e. 
proliferative senescence), and investigating the contribution of environmental factors by 
culturing the cells in human serum from young and old participants and treating them 
with recombinant cytokines.  
 
Several parameters were studied, but the main focus was on ability of myoblasts to 
proliferate and differentiate. Markers of proliferating muscle cells were desmin, NCAM 
and Ki67, and markers of differentiating muscle cells were myogenin and myosin heavy 
chain. Additional parameters observed were DNA damage and analysis of specific 
cytokines in the cell secretome. No differences in any parameter measured were found 
between cells of young and old people. However senescent myoblasts differed 
significantly in all parameters from early passage cells. Differentiation was studied over 
a seven day period. There was a delay of two-four days in the onset of markers 
expression between senescent and early passage cells, as well as a decrease in the 
expression levels of myogenin (50 ± 3% in young, 49 ± 3% in old and 6 ± 1% in 
senescent) after three days of differentiation and myosin heavy chain (MHC; 71 ± 2% in 
young, 70 ± 1.4% in old and 15 ± 1% in senescent) after five days of differentiation. In 
addition, increased DNA damage (7 ± 1% in young, 8 ± 1% in old and 90 ± 4% in 
senescent), increased TGF-β secretion (111 ± 13pg/ml in young, 115 ± 19 pg/ml in old 
and 268 ± 11pg/ml in senescent), and decreased myotube area (151574 ± 22968µm
2
 in 




old and 47765 ± 763µm
2
 in senescent) were observed in 
senescent cells compared to early passage cells. 
 
For influence of environmental factors, freshly isolated cells were cultured in human 
sera or medium with or without cytokines. No differences were observed in the 
myoblasts cultured in sera from young and elderly individuals (Ki67 expression was 85 
± 2% in young and 84 ± 2% in old, and desmin expression was 81 ± 2% in young and 
83 ± 3% in old at three days after isolation). There was, however, a significant decrease 
in desmin and myogenin expression when cells were exposed to TGF-β1 (1 ng/ml), 
TNF-α (1 ng/ml) or IL-1β (1 ng/ml). Committed myoblasts were also cultured in the 
presence or absence of TGF-β1, TNF-α, or IL-1β. Myogenin but not desmin expression 
was significantly inhibited in the presence of cytokines. 
 
These findings support the observation of many studies in vivo in both human and 
animal models which show that satellite cells from old muscle can contribute to muscle 
repair and regeneration. This suggests the satellite cells per se may not be critically 
involved in the mechanism responsible for sarcopenia. However, their sensitivity to 
inflammatory cytokines suggests that if these were present in vivo they would affect the 
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Ageing is associated with a loss of muscle mass. This process is known as 
“sarcopaenia”. It negatively affects the quality of life as functional ability is reduced; 
and there are negative implications given the role of muscle as a source of heat, a 
dynamic metabolic store and a source of protective padding (Young, 1997). Despite 
several investigations, the mechanisms responsible for sarcopenia remain unknown. 
There are numerous factors, both intrinsic and extrinsic to muscle, that may be 
contributed to sarcopenia. These include denervation (Rowan et al., 2012), decreased 
protein synthesis (Short et al., 2004), oxidative damage (Jang et al., 2009, Kondo et al., 
1992), mitochondrial dysfunction (Romanello et al., 2010) and increase in inflammatory 
cytokines (Carlson et al., 2009a, Dobbs et al., 1999, Njemini et al., 2011, Paolisso et al., 
1998, Wei et al., 1992), and decrease in repair mechanisms (Grounds, 1998). 
 
Skeletal muscle is a post-mitotic tissue which has the ability to repair itself in response 
to injury. This process is largely dependent on a specific population of progenitor adult 
stem cells known as satellite cell “myoblasts” (Lepper et al., 2011, Murphy et al., 2011, 
Sambasivan et al., 2011). There is no agreement as to whether defective regeneration of 
aged muscles is determined by changes in systemic factors, factors intrinsic to muscle 
tissue or by impairment of the satellite cells themselves. The work in this thesis uses a 
cell culture approach to study both the inherent effects of age and environmental factors 
on behaviour of human myoblasts. The former are assessed by isolating cells from 
muscle biopsies taken from both young and elderly people and comparing their 
behaviour in culture, whereas the latter are assessed by analysing the response of 
satellite cells to treatment with serum from young and elderly people as well as purified 
cytokines.   
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In chapter one, a review of literature is presented. First, sarcopaenia and its underlying 
mechanisms are detailed. Next, satellite cells are described, and the current ways that 
ageing appears to affect these cells is reviewed. Finally, the effects of cytokines on 
myoblasts proliferation and differentiation are presented. In chapter two, the general 
methodology undertaken in the data chapters is described.  
 
The experimental work is reported in chapters three through to chapter six. Chapter 
three describes how ageing “in vivo” affects the proliferation and differentiation of 
human myoblasts when compared to a model of “in vitro” ageing, namely proliferative 
senescence. Chapter four reports the secretory profile of human myoblast during 
differentiation. Chapters five and six examine the effects of cytokines and human serum 
on the behaviour of human myoblast, respectively. Finally, chapter seven summarises 


















1.1 Population ageing 
The worldwide population is ageing (Degens, 2007, Dunnell, 2007). There is a growing 
proportion of older people and decreasing proportion of children in the general 
population (Tomassini, 2005). Demographic trends estimate that global population of 
those aged 60 over will increase from 600 million (year 2000 estimate) to 2 billion (year 
2050 estimate) (Koopman and van Loon, 2009). Meanwhile, the fertility is declining as 
average life expectancy continues to increase, and people aged 85 years and over 
(Campion, 1994) constitute the fastest growing subpopulation in the developed world 
(Manini and Pahor, 2009, Mazzeo et al., 1998). These changes create significant 
financial pressures on public health and social services. In the UK approximately 40% 
of the health and social care costs of the National Health Service (NHS)  is currently 
spent on those over 65 years of age (Dunnell, 2008).  
 
1.2 Sarcopaenia 
The term was first described by Rosenberg (1989) and derives from the Greek language 
meaning ‘poverty of flesh’ (Rosenberg, 1989, Roubenoff and Hughes, 2000). 
Sarcopaenia is defined as an appendicular skeletal muscle mass divided by height in 
meters, two standard deviations below the mean value for healthy young people under 
30 years of age (Baumgartner et al., 1998). Using this criterion, it is estimated that 25% 
of people above the age of 60 years old and 40% of people over the age of 80 suffer 
from sarcopaenia. Similar results are reported by Ianuzzi-Sucich et al. (2002) and 
Janssen et al. (2002). It is now broadly accepted that sarcopaenia is an intrinsic feature 
of ageing and as such, it cannot be classified as a disease (Roubenoff and Castaneda, 
2001). The most severe effects of sarcopaenia occur when mobility and activity of daily 
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living become markedly impaired and eventually lead to loss of independence, a 
reduced quality of life and an increased risk of falls (Doherty, 2003, Roubenoff, 2000, 
Sayer et al., 2006).   
 
Although inter-individual variation exists, around 10% of the decrease in muscle size 
seems to occur between the ages of 25 and 50, as determined by cross-sectional area of 
whole vastus lateralis muscle obtained from cadavers (Lexell et al., 1988). One 
noteworthy consideration about this seminal study is that the medical history and 
physical activity profile of the subjects examined was not reported. After the age of 50 
the rate of muscle loss increases dramatically and by 80 years a total decrease of 40% in 
muscle size is apparent (Lexell et al., 1988). This decline in muscle mass with ageing is 
associated with both a decrease in the number and muscle fibre size. Lexell et al. (1988) 
has demonstrated that by the eighth decade a 50% reduction in the total fibre number is 
present when compared with muscle tissue in young subjects and that cross sectional 
area of type II fibres is nearly 35% smaller in muscles from older individuals when 
compared with young individuals (Lexell and Taylor, 1991). A growing body of 
literature generally agrees that type II fibre atrophy with age whereas type I fibre size 
remains unchanged (Figure 1.1); (Coggan et al., 1992, Kosek et al., 2006, Petrella et al., 
2006, Verdijk et al., 2007). It must be noted that all subjects on these studies were 
sedentary, suggesting that any differences observed could be either due to age itself or 
simply due to inactivity. Klitgaard and co-workers (1990) showed that elderly strength 
trained subjects have cross-sectional areas larger than of sedentary subjects and similar 
to those of young adult control subjects, suggesting that age-related changes in skeletal 
muscle function may be counteracted by long-term strength training in elderly men. 
Therefore, the model used to study the effects of age needs to be carefully considered, 
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in order to confirm whether differences between young and old individuals are indeed 
due to age or the combination of age and other deleterious factors to health, such as 
inactivity (Lazarus and Harridge, 2010). 
 
Muscle strength and power also decrease with age (Figure 1.2); (Frontera et al., 2000, 
Newman et al., 2003, Skelton et al., 1994). Cross sectional studies indicate that every 
ten years, absolute strength will experience a loss of 8-15% additionally, after the age of 
50, the loss increases to 25-40% (Goodpaster et al., 2006, Hughes et al., 2001, Lindle et 
al., 1997). A loss of muscle power occurs by the age of 40 years in both men and 
women at a much more rapid rate than strength (Izquierdo et al., 1999, Metter et al., 
1997). The effects of loss of muscle power are seen in elite athletes at a similar rate to 
those of healthy untrained individuals (Pearson et al., 2002). This implies that the loss 






















Figure 1.1. Cross sectional area of type I and type II fibre in muscle tissue collected 
from elderly (A) and young (B) males. ATPase histochemistry shows, type I fibres a 
dark/black, and type IIa fibres as areas pale/white and type IIb/IIx with intermediate 
staining. Type II fibres are significantly smaller in the elderly vs. the young. adapted 








Figure 1.2. Age-related decreases in thigh muscle area (based on one-cut computed 
tomography scan) and, knee extensor strength (180°/s) in 78 health persons who did not 




1.3 Underlying causes of sarcopaenia 
1.3.1 Protein turnover 
The maintenance of muscle mass and function relies on a dynamic equilibrium between 
muscle protein synthesis and muscle protein breakdown (Smith and Rennie, 1996). 
Changes in the basal rates of muscle protein synthesis have been demonstrated in some 
(Balagopal et al., 1997, Rooyackers et al., 1996, Short et al., 2004, Welle et al., 1993, 
Yarasheski et al., 1993) but not all studies (Cuthbertson et al., 2005, Volpi et al., 1998, 
Volpi et al., 2001). The loss of muscle mass with age is attributed to a phenomenon 
called ‘anabolic resistance’, where muscle protein synthesis is blunted in response to the 
main anabolic stimuli, i.e. protein intake and/or physical activity (Cuthbertson et al., 
2005, Volpi et al., 2004). For example, older men showed anabolic resistance of muscle 
protein synthesis to feeding, revealing a reduced sensitivity and responsiveness to the 
anabolic effects of protein or amino acid ingestion (Cuthbertson et al., 2005, Katsanos 
et al., 2005, Volpi et al., 2000). Furthermore, older men showed anabolic resistance of 
signalling and muscle protein synthesis following a single bout of resistance type 
exercise (Kumar et al., 2009), but Hasten and co-workers showed that older people 
enrolled in short term resistance exercise study can respond with increased muscle 
protein synthesis rates in similar manner to young subjects (Hasten et al., 2000), 
suggesting that there may be a delay in response, which means it is not observed in 
single bout studies, but is in longer term studies.    
 
1.3.2 Denervation and motor unit loss   
An age-related change in motor units is considered an important factor in the 
development of sarcopaenia (Rowan et al., 2012). A motor unit is defined as the 
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motornuron and all the myofibres it innervates. A month post-denervation, the muscle 
mass of an adult rat hindlimb muscles will decrease by 50% (Gutmann, 1962). This 
process is related to motor neuron cell death or neuromuscular junction remodelling 
both of which occur with age (Ansved and Larsson, 1990, Cardasis and LaFontaine, 
1987, Hashizume et al., 1988, Larsson, 1995, Pettigrew and Gardiner, 1987, Wokke et 
al., 1990). Early studies on ageing human muscle reported a reduction in motor unit 
numbers with an increase in the size of the remaining motor units (Brown, 1972, 
Campbell et al., 1973, Stalberg and Fawcett, 1982, Sica et al., 1976). In human beings, 
half of the motor neurons loss occurs in people above the sixth decade of life 
(Tomlinson and Irving, 1977). Denervation is associated with both fibre type grouping 
and fibre atrophy grouping, resulting in a reduction in the mosaic composition of a 
muscle (Grimby et al., 1982, Larsson et al., 1991, Lexell and Downham, 1991). In 
addition, neuromuscular junction (Lexell, 1997, Luff, 1998) and axon myelination 
(Grover-Johnson and Spencer, 1981, Kazui and Fujisawa, 1988, Knox et al., 1989) 
abnormalities, which should impede stimulation for muscle contractions, are observed 
in aged rodents and humans. These observations are highly suggestive of neural 
degeneration occurring with age. 
 
1.3.3 Apoptosis 
Apoptosis, also known as programmed cell death, is an important process by which the 
cell actively participates in its own destruction (Baker and Reddy, 1998). Accumulated 
evidence suggests that an aged-related acceleration of apoptosis might represent one of 
the major factors to drive age-related muscle atrophy. Microarray experiments report 
that muscle biopsies of older persons show differences of expression in genes involved 
 27 
 
in mediating cellular responses to apoptosis when compared with young subjects (Giresi 
et al., 2005). Loss of nuclei during muscle atrophy is attributed to DNA degradation, 
nuclear condensation and cell fragmentation, all of which are characteristics of 
apoptosis (Allen et al., 1997, Allen et al., 1999, Borisov and Carlson, 2000, Dupont-
Versteegden et al., 2006, Leeuwenburgh et al., 2005, McArdle et al., 1999). Apoptosis 
is classified into two different pathways, caspase-dependent and caspase-independent 
apoptosis (Marzetti and Leeuwenburgh, 2006). Muscle atrophy is associated with an 
increased level of caspase-3 (Leeuwenburgh et al., 2005, Libera et al., 1999, Yasuhara 
et al., 2000). In vitro studies have also shown caspase-3 to be increased during apoptosis 
in myotubes formed by fusion of C2C12 myoblasts (a mouse cell line); (McArdle et al., 
1999). Moreover, Bcl-2, an anti-apoptotic protein, decreases while Bax, a pro-apoptotic 
protein, increases during muscle atrophy (Jin et al., 2001, Libera et al., 1999, Persinger 
et al., 2003, Tews and Goebel, 1997).  
 
1.3.4 Mitochondria and oxidative stress  
It has been proposed that an increased level of oxidative stress and mitochondrial 
dysfunction are potential contributors to sarcopaenia (Jang et al., 2009, Kondo et al., 
1992, Romanello et al., 2010). Ageing has been suggested to be a cumulative accretion 
of mutations in mitochondrial DNA (Wallace, 1999). These mutations can lead to an 
impairment of ATP production and therefore a decline of energy at the tissue level. This 
is largely due to a cytochrome c oxidase (COX) deficiency and the numbers of cells 
containing this deficiency is reported to increase with age in human extraocular muscles 
and in cardiac muscle (Brierley et al., 1998, Muller-Hocker et al., 1992). It has been 
shown that both protein and mRNA level of genes involved in mitochondrial biogenesis 
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decrease in age murine human skeletal muscle compared to the young (Chabi et al., 
2008, Safdar et al., 2010), which eventually contribute to the decreased function of 
these cells, and their increased susceptibility to stress. As mentioned previously, it must 
be noted that all subjects on these studies were sedentary, suggesting that any 
differences observed could be either due to ageing itself or simply due to inactivity. 
Safdar et al. (2010) showed that physically active elderly subject had protein content of 
PGC-1α, a master regulator of mitochondrial biogenesis higher than of the sedentary 
elderly subjects and similar to those of young adult control subjects, suggesting that an 
active lifestyle  is counteract mitochondrial abnormalities associated with ageing.  
 
Mitochondria are the main cellular sites of generation of reactive oxygen species. As a 
result of its proximity to the electron transport chain (ETC), the lack of protective 
histones and the less efficient repair system, mitochondrial DNA is very susceptible to 
oxidative damage by free radicals (Greenlund and Nair, 2003, Wei and Lee, 2002, 
Yakes and Van Houten, 1997). An increase in free radical production, along with a 
decrease in the activity of antioxidative mechanisms, leads to oxidative damage of 
DNA, proteins and lipids in elderly healthy subjects (Fano et al., 2001).  
 
1.3.5 Inflammageing  
Ageing has been associated with systemic low-grade inflammation, so-called 
“inflammageing”. Inflammageing is defined, in part, by increased serum and plasma 
levels of a variety of pro-inflammatory cytokines and growth factors, including IL-6, 
TNF-α, and TGF-β1 (Carlson et al., 2009a, Dobbs et al., 1999, Njemini et al., 2011, 
Paolisso et al., 1998, Wei et al., 1992). Higher cytokine levels are associated with loss 
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of muscle mass and strength with advancing age (Aleman et al., 2011, Cesari et al., 
2005, Pedersen et al., 2003, Schaap et al., 2009, Schaap et al., 2006, Visser et al., 2002) 
and have a negative effect on satellite cell behaviour that may contribute directly to 
sarcopenia. This discussed further in section 1.5.  
 
1.3.6 Impairment of satellite cell function in repair and hypertrophy  
Skeletal muscles are the most abundant tissue in the human body and comprise 
approximately 40-45% of the total body mass. Throughout life, skeletal muscles have a 
remarkable ability to repair after damage (McCroskery et al., 2005). The tremendous 
capacity for mammalian skeletal muscle regeneration is demonstrated by the 
histological examination of skeletal muscle specimens in rodents following chemical 
insult, where large areas of damage are restored to their normal architectural integrity 
within ten days (Otto et al., 2008, Yan et al., 2003). The remarkable regenerative 
capacity of postnatal skeletal muscle has been found to be largely dependent on a 
specific population of progenitor adult stem cells known as satellite cells. 
Transplantation of freshly isolated myofibres into the radiation-ablated muscles of 
dystrophic mdx-nude mice, has provided important evidence that the satellite cells are 








Recent studies using genetic ablation of the satellite cell pool in adult mice have 
provided evidence that muscle regeneration is entirely dependent on the presence of the 
satellite cells (Lepper et al., 2011, Murphy et al., 2011, Sambasivan et al., 2011). 
Satellite cells also have their capacity to “self renew” during the regeneration process, 
ensuring that undifferentiated precursors are available for future repair (Collins, 2006, 
Collins and Partridge, 2005), it is now widely accepted that satellite cells are 
mononucleated myogenic precursor cells (myoblasts), that adhere to existing muscle 
fibres under the basal lamina (Bischoff, 1975) and are present throughout the lifespan of 
all myofibres. They play a major role in the maintenance and repair of postnatal skeletal 
muscle tissue. Satellite cells are normally present in a quiescent undifferentiated state, 
but when activated in response to muscle damage by injury or exercise, they have the 
ability to proliferate, migrate to the site of injury and fuse with existing fibres for 
regeneration and hypertrophy (Bischoff, 1975, Konigsberg et al., 1975, Morgan and 
Partridge, 2003, Moss and Leblond, 1971, Snow, 1977b); (Figure 1.4). As this thesis is 
concerned with the in vitro behaviour of satellite cell derived myoblasts obtained from 
human biopsies, Section 1.4 details several aspects of satellite cells from their 
identification in the early 1960s to details of markers used in their identification. The 
effect of age on satellite cells is addressed in detail in section 1.4.5. 
 
Although satellite cells have been shown to play a central role in muscle regeneration, 
other cell populations have also been implicated in this process. For example, a 
pioneering study by Ferrari et al. (1998) showed that bone marrow derived cells can 
participated to muscle regeneration and are capable of differentiating into myofibres 
following injury. More recently, genetic ablation of “muscle side population cells” 
demonstrated that skeletal muscle regeneration is delayed (Doyle et al., 2011). These 
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cells are distinct from satellite cells by their ability to efflux the dye Hoechst 33342 and 
show a unique pattern on fluorescence-activated cell sorting analysis (Goodell et al., 
1996). Subsequently, several other cell types have been reported to incorporate into 
muscle during regeneration, including mesoangioblasts (Sampaolesi et al., 2003), 
pericytes (Dellavalle et al., 2007), and PW1
+ev
 interstitial cells (Mitchell et al., 2010). 
The functional interactions between satellite cells and other muscle residing cell types 
following muscle injury are unclear and the role of the non-muscle derived cells in 
sarcopenia is even less so.   
   
1.4 Satellite cells 
1.4.1 Identification and morphology of satellite cells   
Satellite cells were first identified in 1961 based on their anatomical position using 
electron microscopic examination of the frog tibialis anticus muscle, located between 
the plasma membrane and the basal lamina of muscle fibres (Mauro, 1961). Human 
satellite cells are found to be shorter in length than myonuclei (8 µm compared to 11 
µm); (Watkins and Cullen, 1986) and display cytoplasm with few organelles 
(ribosomes, rough endoplasmic reticulum, and Golgi apparatus), and high amounts of 
nuclear heterochromatin (Schultz, 1976). These features demonstrate that satellite cells 
are transcriptionally less active than myonuclei, i.e. they are in a quiescent state (Schultz 
et al., 1978). Activated satellite cells exhibit an altered morphology. The cytosolic 
fraction of the cells will have a larger volume and cell extensions will start to form to 
facilitate movement, there will be an increase in the number of organelles and a 
reduction in heterochromatin level (Hawke and Garry, 2001, Schultz, 1976, Schultz and 
McCormick, 1994); (Figure 1.3). Based on their morphology and position several lines 
 32 
 
of evidence have confirmed the presence of skeletal muscle satellite cells in a number of 














Figure 1.3. Satellite cell location in an adult muscle fibre. 
In uninjured muscle fibres, the satellite cell is quiescent and rests in an indentation in 
the adult muscle fibre. The satellite cells can be distinguished from the myonuclei by a 
surrounding basal lamina and more abundant heterochromatin. When the fibre becomes 
injured, the satellite cells become activated and increase their cytoplasmic content. The 
cytoplasmic processes allows for chemotaxis of the satellite cell along the myofibre. 







1.4.2 Molecular markers of satellite cells 
Satellite cells can be identified using immunhistochemistry and immunocytochemistry, 
where antibodies bind to a specific antigens, and are viewed under a microscope. 
Marker specific to each phase of satellite cell activation exist (figure 1.4). Quiescent 
satellite cells are most commonly identified by their characteristic expression of the 
paired box transcription factor 7 gene (Pax7) mRNA and protein (Day et al., 2007, 
Zammit et al., 2006b). Myoblasts can be obtained from muscle tissue and cultured in 
vitro where they also express muscle specific markers such as Pax7, Myf5 and MyoD. 
When induced to differentiate, they stop proliferating, begin expressing myogenin and 
fuse together forming multinucleated cells called myotubes. Myotubes are post-mitotic 
and expresses terminal markers of muscle differentiation such as sarcomeric myosin 
heavy chain (MHC) (Zammit et al., 2006a). Although a comprehensive list of satellite 
cell markers are presented in Table 1.1, only satellite cell markers used in the 
experimental sections of this study will be discussed in detail below.  
 
Several antibodies have been reported to recognise satellite cells in adult skeletal muscle 
during various stages of myogenesis. The first antibodies used to distinguish satellite 
cells from other cells were Leu19/CD56 which recognises the neural cell adhesion 
molecule (NCAM) (Illa et al., 1992, Schubert et al., 1989). NCAM is expressed during 
early myogenesis and in adult satellite cells. A range of researchers have reported that 
NCAM is a useful marker for satellite cells in biopsy samples of human muscle. This is 
a consequence of, the fact that it binds to quiescent as well as activated satellite cells 


















Figure 1.4. Schematic representation of satellite cell activation and progression through 
the myogenic program. Quiescent satellite cells, underneath the basal lamina of muscle 
fibres, express Pax7 and Myf5. Upon activation, they up-regulate MyoD and divide to 
produce a pool of muscle precursor cells (mpc). Satellite cell progeny then follow one 
of two fates. They may down-regulate MyoD and self-renew to give rise to a Pax7 
expressing satellite cell. Alternatively, they may differentiate, down-regulating Pax7, 
Myf5, and MyoD and expressing MRF4 and myogenin, eventually fusing either to form 









  Table 1.1. Markers of satellite cells  
  Modified and adapted from (Boldrin et al., 2010). 
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Desmin is an intermediate filament protein found in high abundance in the cytoskeleton 
of muscle cells (Capetanaki et al., 2007, Lazarides and Hubbard, 1976). Desmin is the 
most widely used marker for human myoblasts in culture as there is a reliable, 
commercially available monoclonal antibody. Desmin is present in human and animals 
proliferating muscle precursor cells in culture, in regenerating muscle fibres at 24 hours 
or more after injury and following the fusion of myoblasts (Allen et al., 1991, Bockhold 
et al., 1998, Brocks et al., 1991, Jacquemin et al., 2004, Schafer et al., 2006).  
 
MyoD belongs to a family of proteins known as the myogenic regulatory factors 
(MRFs) and is required for determination of myoblasts into the myogenic lineage 
during embryonic development (Cao et al., 2006, Megeney et al., 1996). MyoD is not 
normally expressed in adult myofibres or quiescent satellite cells, but is expressed upon 
satellite cell activation. In cultured human myoblasts, it continues to be expressed 
during differentiation and after fusion into myotubes (Dellavalle et al., 2007). Both in 
vivo and in vitro studies have demonstrated that MyoD-deficient myoblasts have a 
reduced differentiation potential presented as an impaired ability to fuse, resulting in a 
reduction in the number of myotubes that can be generated (Yablonka-Reuveni et al., 
1999, Megeney et al., 1996, Montarras et al., 2000, Sabourin et al., 1999). These results 
suggest that MyoD not only is an important marker for satellite cells, but is also 
responsible for inducing myogenic differentiation. Myogenin, also a member of the 
myogenic regulatory factor family, is expressed during the early phases of 
differentiation (Dellavalle et al., 2007). Myogenin is implicated in cell cycle arrest and 
regulates phenotypic differentiation and subsequent cell fusion (Andres and Walsh, 
1996). Myosin heavy chain (MHC) is a muscle specific protein which forms the thick 
myofilaments in skeletal muscle fibres, it is composed of two heavy chains and four 
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light chains (Cripps et al., 1999). MHC is expressed during early and late stages of 
myogenic differentiation (Soulez et al., 1996). 
 
Finally, Ki67 is a protein used as a marker of proliferation (Gerdes et al., 1984, 
Silvestrini et al., 1988). The Ki67 antigen is present in cells, including satellite cells, 
during all phases of the cell cycle, and is often used to define the growth fraction of 
satellite cells population (Gerdes et al., 1984, Mackey et al., 2009, Ono et al., 2010). 
The identity of the Ki67 antigen has not been reported.  
 
1.4.3 The role of satellite cells in adult muscle 




Despite the strong relationship between muscle regenerative ability and the presence of 
satellite cells, the relevance of satellite cell contribution to hypertrophy of human 
skeletal muscle remains controversial. It has been shown in rodents that when satellite 
cell proliferation is inhibited by gamma irradiation, there is a reduced hypertrophic 
response to overload (Phelan and Gonyea, 1997, Rosenblatt and Parry, 1992). In 
contrast, recent studies using genetic ablation of the satellite cell pool in adult mice have 
provided evidence that satellite cells are not always essential for hypertrophy 
(McCarthy et al., 2011). Studies in human muscle that examine the relationship between 
fibre cross sectional area, myonuclear number and satellite cell activation; suggest that 
existing myonuclei are transcriptionally able to sustain an area of muscle fibre 
equivalent to 2000µm
2
, known as the myonuclear domain (Cheek, 1985, Petrella et al., 
2006). At the onset of hypertrophy, individual myonuclei increase their transcriptional 
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activity, and consequently their myonuclear domain will enlarge to support moderate 
enhancement of cytoplasmic volume, this allows the fibre to increase by up to 26% or 
until a certain limit of the myonuclear domain has been reached (Kadi et al., 2004b, 
Petrella et al., 2006). Any subsequent hypertrophy beyond this limit in theory requires 
the addition of new myonuclei and satellite cell fusion.  
  
1.4.4 The origin of satellite cells 
The origin of satellite cells has been a topic of long-lived debate. It is widely accepted 
that satellite cells are originally derived from the somites, as evidence by several study. 
Early experiments using a quail-chick chimera model point out that satellite cells derive 
developmentally from the somites (Armand et al., 1983). More recently, this concept 
has also been confirmed using green fluorescent protein lineage tracing and the quail–
chick grafting techniques demonstrated that satellite cell originate from somites and in 
particular from a Pax3/7 positive population of cells located in the central region of the 
dermomyotome of the somite (Gros et al., 2005). However, different origins have been 
proposed for satellite cells such as the dorsal aorta, other blood vessels or the bone 
marrow (De Angelis et al., 1999, Ferrari et al., 1998, Gussoni et al., 1999, Seale et al., 
2001). Thus, these results suggested that satellite cells are not homogeneous cells and 
may actually derive from sources other than the somite during embryonic development. 
As discussed previously, it has been demonstrated that satellite cells are essential for 
muscle regeneration. It is thus unlikely that non muscle stem cells make any significant 
contribution to adult muscle regeneration although they may occasionally be identified 




1.4.5 Effects of ageing on satellite cells 
During early postnatal growth, satellite cells account for 30-35% of sublaminar muscle 
nuclei in mice, declining to approximately 5-7% in adults (Allbrook et al., 1971, 
Cardasis and Cooper, 1975, Schultz, 1976). Some controversy surrounds the loss of 
satellite cells with age, as some studies document relatively equal numbers in young and 
old individuals (Dreyer et al., 2006, Roth et al., 2000). Others report a decline in 
satellite cells content with increasing age (Kadi et al., 2004a, Renault et al., 2002, 
Verdijk et al., 2007). Verdijk et al. (2007) reported that satellite cell loss was restricted 
to the type II muscle fibres and one possible explanation is that satellite cell loss is fibre 
type specific. The fibre type composition of the specific muscle being examined or that 
is found in the biopsy material under examination may determine whether an age 
associated decrease in satellite cell numbers is seen. 
 
There is no agreement as to whether defective regeneration of aged muscles is 
determined by changes in systemic factors or by impairment of the satellite cells 
themselves. The first experiments to suggest a “systemic” impairment to muscle repair 
and regeneration were performed by Carlson and Faulkner (1989) who showed that 
cross age transplantation experiments of the right EDL muscle between young (2-3 
months) and old (24 months) inbred Wistar rats resulted in two fold increases in muscle 
mass and strength when elderly muscle was grafted onto a younger animal as compared 
to autografted to elderly muscle. This study suggested that the poor regeneration of 
muscles in old animals is a function of the environment for regeneration provided by the 
old host and not a function of the aged muscles themselves. Long-term reinnervation 
deficiencies in the elderly hosts were subsequently implicated in this phenomenon 
(Carlson et al., 2001).  
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Further support for the findings of Faulkner and Carlson (1989), were reported in a 
parabiotic study where pairs of mice were connected by the circulatory system, so that 
the regenerating tissues of one animal were exposed to the circulating factors of another 
(Conboy et al., 2005). This was performed pairs of animals of the same age (isochronic 
parabioses) or different ages (heterochronic parabiosies). In this study, parabiotic 
pairings of young and old mice were followed by exposure of the muscle to dry ice 
(cryogenic) injury which this resulted in satellite cell activation. The young isochronic 
parabionts regenerated well whereas the old isochronic parabionts regenerated poorly as 
shown by failure of myotube formation, and prominent fibrosis at the site of injury. 
There was a significant improvement in the regeneration of muscles in elderly mice 
which were paired with younger mice compared to aged isochronic pairings. The 
appearance of newly formed fibres (identified by the expression of neonatal myosin 
heavy chain) in the elderly animals attached to a young partner was similar to that seen 
in young mice. 
 
The molecular mechanism implicated in the above response and shown to be directly 
linked with impaired muscle regeneration is the Notch signalling pathway (Conboy et 
al., 2003). In young isochronic and heterochronic parabionts there was a marked up-
regulation of cell surface protein Delta-1 (an activator of the Notch signalling pathway) 
in satellite cells, whereas Delta-1 induction was lacking in the old, isochronic parabionts 
(Conboy et al., 2005). Thus, heterochronic parabiosis not only improves the 
proliferative response of satellite cells, it also restores the key molecular signalling in 
these cells that is essential for muscle regeneration. A subsequent study suggested that 
the cause of impaired satellite cell proliferation is an imbalance between Notch and 
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TGF-β/pSmad signalling pathway which are suggested to inhibit satellite cell 
regenerative potential (Carlson et al., 2008, Carlson et al., 2009b). 
 
Strong evidence implying involvement of a circulating factor in satellite cell 
determination and proliferation comes from in vitro experiments in which a mouse 
muscle was extracted from young C57-BL/6 male mice, and cultured in serum obtained 
from elderly (22-24 months) or young (2-3) mouse (Carlson and Conboy, 2007). Two 
fold increases in desmin, BrdU and Myf5 expression were found in cells cultures in 
young serum as opposed to elderly serum, indicating that greater muscle proliferation in 
a more youthful circulating environment. More recently, in vitro experiments in which 
human myoblasts from young and old subjects were cultured in the presence of young 
or aged blood sera (isochronic and heterochronic) (Carlson et al., 2009b), showed 
similar results to that obtained in mice. Cells exposed to young human serum had 
increased expression of the proliferating muscle markers desmin and Brdu compared to 
cells cultured in elderly human serum. In contrast, However, Bayer et al. (2012) found 
that no difference in tendon cell proliferation and collagen expression when cells were 
exposed to human serum from young and elderly subjects.  
 
The results of the experiments described above thus suggest that there is an age 
associated decline in the properties of the circulatory environment which impairs the 
regeneration potential of aged satellite cells. Ageing has been shown to result in 
increased Wnt signalling in serum, which is associated with increased fibrosis (Brack et 
al., 2007), increased serum levels of TGF-β, which inhibits satellite cell behaviour 
(Carlson et al., 2009a), reduced serum levels of IGF-1 which act as a potent mitogen of 
satellite cells in culture (Allen and Boxhorn, 1989, Goldspink and Harridge, 2004).  
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Numerous other causes have been suggested to affect the efficiency of skeletal muscle 
regeneration within aged environment. These include reduced capillarization (Ryan et 
al., 2006), thickening of the basal lamina (Snow, 1977a), and increase in collagen 
content within the muscle (Alnaqeeb et al., 1984).  
 
In contrast to the in vivo and in vitro observations discussed above, it has been shown 
that human myoblasts from old donors can contribute myonuclei very efficiently to 
regenerating mouse muscle in vivo (Schafer et al., 2006). Single fibre grafting 
experiments in mice have shown that satellite cells from old animals can contain 
equivalent in vivo myogenic and self-renewal potential to that of young animals 
(Collins et al., 2007), and studies involving transplantation of whole muscles have not 
reported differences in myotube formation between elderly and young muscles grafted 
into elderly or young animals (Smythe et al., 2008). This suggests no differences in the 
regeneration of muscle and formation of myotubes with age. There was, however, a 
delay in myotube formation observed in the older animals. A more recent study by 
Shavlakadze et al. (2010) similarly showed a delay in the onset of regeneration after 
autografting muscle into a geriatric mouse host, though again the long term formation of 
new muscle was unaffected and there was no effect of the geriatric host on regenerating 
muscle. Other animal studies which have used a variety of different models including 
denervation (Dedkov et al., 2003), cross transplantation in mdx mice (Boldrin et al., 
2009) as well as chronic low-frequency electrical stimulation (Putman et al., 2001) have 





Several studies have found age associated differences when compared in vitro 
differentiation of primary human cells from donors of different ages. Fulle et al. (2005) 
compared human muscle cells obtained from a newborn (5 day old), young (29 years 
old) and old (71 years old) subjects with 85, 71 and 47% of desmin cells respectively. 
They found that the percentage of MHC positive cells (Fusion index) had decreased in 
the elderly subject after 5 days in culture when compared to newborn and young 
subjects. This status was suggested to be due to a decrease in antioxidant capacity of 
Catalase and Gluthatione transferase in satellite cells derived from the elderly compared 
to that in cells isolated from young individuals. Subsequent experiments by this group 
have shown a 20% decrease of fusion index (as measured after 7 days of in vitro 
differentiation and expressed as the percentage of nuclei in myosin heavy chain positive 
cells containing at least two nuclei) in elderly subjects (83 ± 6 years old, n=3) when 
compared to young subjects (30 ± 2 years old, n=3); (Beccafico et al., 2007). They also 
have shown that myotubes derived from elderly subjects are thinner and contain few 
myonuclei compared to the ones derived from the young individual. 
 
Beccafica et al. (2010) isolated myoblasts from the vastus lateralis muscle of 10 young 
(29 ± 6 years old) and 11 old (77 ± 6 years old) and cultured them in either growth 
media or differentiation media. These authors showed that myoblasts from older 
subjects displayed lower levels of Brdu incorporation when compared to younger 
subjects thus suggesting impaired proliferation in the elderly cells. Western blotting 
analysis revealed no expression of the early myogenic differentiation marker; 
myogenin; or the terminal differentiation marker, MHC in myoblasts derived from older 
subjects compared to younger subjects. In addition, when compared to those of younger 
subjects, the older myoblasts displayed significantly higher levels of S100B, an 
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intracellular protein known to inhibit myoblast differentiation, and lower levels of 
membrane-bound RAGE, a receptor promoting myoblast differentiation. 
 
Corbu et al. (2010) isolated myoblasts from the vastus lateralis muscle of 3 young (from 
4 months to 16 years old) and 6 old (74-76 years old) subjects. These authors showed 
that the myogenic potential seemed to be compromised in the aged of human muscle 
cells. However, it may be difficult to draw parallels between the old subjects (74-76 
years old) and the young controls aged from 4 months to 16 years old used in this study; 
the hormonal profile during childhood and puberty is higher in growth factors than in 
adulthood, which might explain the marked increase in myogenicity seen in the younger 
cells.  
 
In another human study, Lorenzon et al. (2004) compared human muscle cells obtained 
from a 2 year old, 21 year old, 48 year old and 76 year old. They found fusion index and 
number of nuclei per myotube were decreased between the 21 and 76 year old subjects 
after 4, 6 and 9 days in culture. Furthermore, myotubes formed from satellite cells 
extracted from aged donors show a delay in the maturation of the excitation-contraction 
coupling mechanism when compared to young donor cells. Jacquemin et al. (2004) 
compared cells from biopsy tissue extracted from a 5 day old, 17 year old and 65 year 
old human. They found fusion index and the mean number of nuclei per myotube were 
decreased between the 17 and 65 year old subjects after 3 days in culture. Whilst a 
further in vitro study showed that myoblasts extracted from muscles of elderly people 
do not fuse as efficiently as those from younger subjects (Pietrangelo et al., 2009). This 
was suggested to be due to accumulation of oxidative damage, altered turnover of 
cytoskeleton and extracellular matrix degradation, and activation of atrophic pathways 
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through the FOXO-dependent program following analysis of mRNA expression profiles 
in these cells from microarray analysis.  
 
Critically, several of the studies described above draw conclusions from comparison of 
very small numbers of subjects, often only one from each age group (Fulle et al., 2005, 
Jacquemin et al., 2004, Lorenzon et al., 2004) or from comparing populations that do 
not have equivalent proportions of cells expressing desmin (Beccafico et al., 2007, 
Pietrangelo et al., 2009) or have not been characterised in terms of desmin content 
(Beccafico et al., 2010). Desmin content reflects the proportion of myogenic cells in the 
culture and therefore determines differentiation potential of a population independently 
of age. Studies comparing only one subject from each age group do not provide strong 
enough evidence on their own of age related effects, since in the human population 
there are very large variations in factors other than age (i.e. genetic and lifestyle factors) 
that could provide an explanation for the effects observed. 
 
1.5 In vitro ageing 
1.5.1 Replicative senescence 
Serial passage of normal somatic cells ultimately results in a state of permanent growth 
arrest called cellular senescence. Such a phenomenon also known as replicative 
senescence was first described by Leonard Hayflick and Paul Moorhead who observed 
that normal human fibroblasts had a limited life span after being serially passaged in 
culture (Hayflick and Moorhead, 1961). They described three phases in the growth 
history of human diploid cell strains (Figure 1.5). Phase I lasts 1 to 3 weeks and is 
described as the primary culture phase when the cells have been freshly freed from 
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intact tissue and cover the surface of the culture flask. Phase II lasts 2 to 10 months and 
represents the period when cells divide in culture. Phase III occurs when cell replication 
progressively slows until the cells ultimately stop dividing and enters replicative 
senescence. Even though initial experiments were with fibroblasts, replicative 
senescence has been observed in other cell types including satellite cells, keratinocytes, 
endothelial cells and lymphocytes (Decary et al., 1997, Kang et al., 1998, Spaulding et 














Figure 1.5. History of cell strains and the phenomenon of cell alteration during 






Senescent muscle cells differ in a number of ways from early passage cells. 
Morphologically, senescent cells display a larger and more flattened morphology with 
an increased in microfilament content (Renault et al., 2000). Senescent cells can be 
identified in vitro by a specific marker of senescence; senescence associated β-
galactosidase (Dimri et al., 1995, Gruber et al., 2010) and these cells display dramatic 
changes in chromatin structure, with formation of senescence associated 
heterochromatin foci (SAHF) (Narita et al., 2006). Furthermore, senescent cells are 
characterised by an irreversible G1 growth arrest with up-regulation of the CDK 
inhibitors p16 and p21 (Stein et al., 1999). Although unable to replicate, senescent cells 
can remain metabolically active for a long periods of time and are resistant to apoptosis 
(Gruber et al., 2010, Hampel et al., 2005).   
 
One mechanism that is suggested to lead to replicative senescence is telomere 
shortening. Telomeres are TTAGGG repeats located at the end of linear chromosomes 
that protect the DNA ends from degradation and recombination. It has commonly been 
thought that telomere loss acts as a mitotic clock that signals senescence when one or 
more telomeres reach a critical length (Chan et al., 2001, de Lange, 2005, Mouly et al., 
2005). In eukaryotes, telomere shortening occurs with every round of cell division due 
to the inability of DNA polymerase to copy the ends of linear molecules (Blasco, 2005, 
Bodnar et al., 1998). Eventually telomeres become critically short, which in turn 
induces a DNA damage response characterized by the formation of double strand DNA 
breaks containing the phosphorylated histone H2AX, that activate the p53 tumor 
suppressor protein resulting in up-regulation of cell cycle inhibitors and telomere-
initiated senescence (Celeste et al., 2002, de Lange, 2005, von Zglinicki et al., 2005). 
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1.5.2 Replicative potential and senescence in human myoblasts 
Myoblasts obtained from healthy people appear to show different proliferative potential 
depending on the age of the individual at the time of the isolation. Myoblasts extracted 
at birth can undergo 60-70 population doublings (PD) in culture before entering 
replicative senescence. Myoblasts obtained from a five month old individual they 
underwent 43 PD whereas and after 20 years the number of PD was 15-25 before cells 
entered replicative senescence (Decary et al., 1997). Interestingly, the dramatic decrease 
observed in the in vitro replicative potential of myoblasts occurs from birth to 20 years 
of age followed by a period of relative stability thereafter (Decary et al., 1997). This 
initial decrease in replicative potential is thought to be related to the rapid growth of 
skeletal muscle during childhood and adolescence. Stabilization of the in vitro 
replicative potential of adult myoblasts is thought to coincide with decreased muscle 
growth. 
 
Senescent myoblasts have been used as a model to study muscle ageing. Senescent 
myoblasts exhibit a lower fusion index and fewer nuclei per myotube than proliferating 
(early passage) or “young” cells (Bigot et al., 2008). The expression of two fibroblastic 
markers, CTGF (connective tissue growth factor) and collagen IV also increase in 
senescent myoblasts. Machida et al. (2004) have shown decreased proliferation and 
differentiation potential in muscle-derived stem cells after passaging procedure 
(Machida et al., 2004). They showed that the percentage of cells that were positive for 
the myogenic markers desmin, MyoD and Pax7 was reduced from 90% to 55%, and the 
percentage of nuclei in myotubes decreased from 46.7% to 12.5% after the third 
passage. More recently, C2C12 mouse skeletal myoblasts were used to investigate the 
impact of serial passaging on the behaviour of myoblasts (Sharples et al., 2011). 
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Following multiple divisions, these cells displayed a reduced levels of muscle creatine 
kinase (marker of differentiation) compared to control cells. Furtheremore, these cells 
had significantly reductions of IGF-1, MyoD and myogenin together with elevated 
IGFBP5. Taken altogether, these studies suggest that serial passaging procedure has a 
detrimental effect on myoblast performance, but it remains to be determined if this 
reflects the ageing process in vivo.  
 
1.5.3 Senescence-Associated Secretory phenotype (SASP) 
The conditioned medium of senescent cells in vitro is enriched with secreted proteins 
(Krtolica and Campisi, 2002, Shelton et al., 1999). The SASP concept was first 
described by the Campiai group, when they realized that secreted factors from senescent 
fibroblasts promote the development of age-related epithelial cancer. A series of recent 
papers have identified a range of cytokines involved in SASP (Coppe et al., 2010, 
Coppe et al., 2008, Rodier et al., 2009). Coppe et al. (2008) compared proteins secreted 
by pre-senescent human fibroblast with senescent human fibroblast cells by incubating 
each culture in serum free-medium. Using antibody arrays, the study highlighted the 
increased secretion of IL-6, IL-7, IL-8, IGFBPs and TNF-receptors in senescent 
conditioned medium when compared to pre-senescent conditioned medium. 
Furthermore, SASP induction was observed in a number of different cell types, 
including human epithelial cells (Coppe et al., 2008), and human oral keratinocytes 
(Kim et al., 2011b). Current interest in the senescent secretome has revealed several 
molecules that are important players in extracellular matrix (ECM) remodelling. A 
group of factors that have been identified as potential regulators of the ECM and 
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secreted by senescent cells which include IGF1, Wnt, Plasmin and TGF-β (Kuilman and 
Peeper, 2009).   
 
Among the factors identified in the SASP, three are of particular relevance to the 
present work as they have been shown to affect myoblast behaviour. These are TGF-β, 
TNF-and IL-6.  
    
1.5.3.1 Transforming Growth Factor Beta (TGF-β) 
TGF-β belongs to a family of proteins that includes nodals, activins, bone morphogenic 
proteins (BMP), anti-Mullerian hormone, myostatin and other related factors found in 
vertebrates, insects, and nematodes (Massague, 1990, Massague, 1998). Five unique 
isoforms are found in different species: TGF-β 1, 2 and 3 are mammalian, TGF-β4 are 
avian, and TGF-β5 are amphibians isoforms (Roberts and Sporn, 1992). TGF-β was first 
described as sarcoma growth factor, secreted by transformed fibroblasts (de Larco and 
Todaro, 1978). TGF-β1 is also produced by several cell types including: platelets, 
lymphocytes, macrophages, neutrophils, injured skeletal muscle, and C2C12 mouse 
skeletal myoblasts (Assoian et al., 1987, Assoian et al., 1983, Grotendorst et al., 1989, 
Haugk et al., 1995, Henningsen et al., 2010, Kehrl et al., 1986, Peters et al., 2005). 
TGF-β1 is a pleiotropic cytokine which appears to play an important role in cell 
proliferation, differentiation, migration, angiogenesis, apoptosis, inflammation and 
scarring in various tissues (Heldin et al., 2009, Lawrence, 1996, Massague, 1998, 





TGF-βs are synthesised as homodimeric pro-proteins (proTGF-β) that are 
proteolytically processed in the Golgi apparatus by furin-type enzymes. Furin cleaves 
the dimeric TGF-β-propeptides (the latency-associated protein“LAP”) from the mature 
TGF-β homodimer which remains non-covalently bound to the growth factors. This 
complex is known as the small latent complex (SLC). Once the SLC has been targeted 
to the extracellular matrix (ECM), LAP covalently binds to latent TGF-β binding 
protein (LTBP) to form the large latent complex (LLC) via disulfide bonds (Figure 1.6). 
LTBPs may function to facilitate secretion of the TGF-β-LAP complex and to promote 
targeting of TGF-β to the ECM, where activation takes place. The TGF-βs are primarily 
stored in this latent form (L-TGF-β) in the ECM and require activation before being 
able to bind to their cell surface receptors and exert an effect on their target (Annes et 
al., 2003, Massague and Chen, 2000, Rifkin, 2005).  
 
TGF-βs act through binding to TGF-β type I and TGF-β type II receptors that form a 
heteromeric complex with the ligand (Derynck and Feng, 1997). These receptors are 
serine/theronine kinase receptors. In the complex, the binding of TGF-β to the type II 
receptor, activates and recruits the type I receptor to the complex to initiate a TGF-β 
signalling response to the nucleus (Verrecchia and Mauviel, 2002). Subsequently, type I 
receptor phosphorylates transcriptional factors of the Smad family which are 
translocated to the nucleus to mediate the effects of TGF-β at the cellular level (Figure 
1.7) (Chaudhury and Howe, 2009). Furthermore, TGF-βs also activate different non-
Smad pathways, including PI3K, Ras, Par6, Jnk/p38/MAPK pathways, some of which 























Figure 1.6. The TGFβ large latent complex (LLC). The LLC comprises TGFβ (black), 
LAP (red) and LTBP. TGFβ and LAP are proteolytically separated at the site indicated 
by the arrowhead. After processing, TGFβ remains noncovalently associated with LAP. 
LAP and LTBP are joined by disulfide bonds (light blue lines). The LLC is covalently 
linked to the extracellular matrix (ECM) through an isopeptide bond (green) between 
the N-terminus of LTBP (somewhere between EGF like domain and the hinge domain, 
arrow) and a currently unidentified matrix protein. The hinge domain (arrow) of LTBP 
is a protease-sensitive region that allows LLC to be proteolytically released from the 

























Figure 1.7. Schematic Representation of Canonical and Non-canonical TGFβ Signaling 











The ability of TGF-β1 to inhibit myoblast differentiation and to depress proliferation 
has been documented (Allen and Boxhorn, 1987, Greene and Allen, 1991, Massague et 
al., 1986). There is some evidence to suggest that TGF-β1 levels become elevated with 
age and this has been suggested to be the mechanism by which satellite cell activation is 
impaired in older muscle (Carlson et al., 2009a, Carlson et al., 2009b). Culturing C2C12 
myoblasts in the presence of 5 ng/ml of human recombinant TGF-β1 has been shown to 
increase proliferation and inhibit differentiation (Schabort et al., 2009). Molecular 
analysis has indicated that this effect of TGF-β1 results from the increased nuclear 
localisation of proliferating cell nuclear antigen (PCNA), MyoD degradation, and 
decreased p21, myogenin and MHC expression. In this experiment the inhibition of 
differentiation was reversible once TGF-β1 was eliminated. Subsequent studies have 
shown that TGF-β1 decreases fusion of C2C12 myoblasts in an isoform- independent 
manner (Schabort et al., 2011). 
 
More recently, human myoblasts were cultured in the presence of 25 ng/ml human 
recombinant TGF-β1 vs. control (Carlson et al., 2009b). It was found that myoblast 
proliferation and differentiation was dramatically reduced by TGF-β1. It has been 
postulated that TGF-β1 is capable of maintaining satellite cell in quiescence following 
isolation for cell culture, a process which normally involves their activation, in a dose 
dependent manner (3, 10, and 30 ng/ml) (Rathbone et al., 2011). Beggs et al. (2004) 
demonstrated that during proliferation and differentiation, treatment with TGF-β1 (1 
ng/ml) increased the phosphorylation of Smad2/3 and decreased MyoD and myogenin 
expression. This suggest that Smad acts as downstream of TGF-β1 to inhibit the 
function of myoblasts. 
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1.5.3.2 Tumour Necrosis Factor Alpha (TNF-α) 
TNF-α, an endogenous cytokine, is secreted by a number of cells including: fibroblast, 
muscle, macrophages, neutrophils, adipose tissue, vascular smooth muscle and vascular 
endothelium (De Rossi et al., 2000, Hotamisligil et al., 1995, Liu et al., 2000, Zoico and 
Roubenoff, 2002). TNF-α is released after proteolytic cleavage by the TNF converting 
enzyme (TACE, a member of the a-disintegrin-and-metalloproteinase (ADAM) family), 
and mediated its effects via two distinct receptors: type 1 (TNFR1) and a type 2 
(TNFR2) (Sethi and Hotamisligil, 1999). 
 
TNF-α is a pleiotropic pro-inflammatory cytokine, which has been considered a 
pathological factor in different condition such as muscle wasting (Bhatnagar et al., 
2010). The muscle wasting occurs via the activity of several important pathways (Figure 
1.8). TNF-α activates caspase-8 (apoptosis pathway), the ubiquitin proteasome pathway 
(protein breakdown and muscle atrophy pathway), MAPK family pathway, and reduces 
the rate of protein synthesis which ultimately compromised skeletal muscle regeneration 
(Gomes et al., 2001, Li et al., 1999, Llovera et al., 1997, Mercier et al., 2002, Moresi et 
al., 2008, Phillips and Leeuwenburgh, 2005, Reid and Li, 2001). 
 
Langen et al. (2004) demonstrated that in C2C12 myoblasts, 10 ng/ml TNF-α initially 
activated proliferation by increasing cell cycle progression and subsequently reduced 
differentiation. This effect was associated with activation of the NF-кB pathway, which 
has a role in destabilization of MyoD (Guttridge et al., 2000). This effect was reversible 
once TNF-α was removed (Langen et al., 2001). It has also been shown that creatine 
kinase, MyoD and myogenin expression are reduced in the presence of 20 ng/ml of 
TNF-α when compared with control cells. Similar results were reported by Foulstone et 
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al. (2004), using primary culture human myoblasts (20 ng/ml), and Saini et al. (2008), 
using C2C12 myoblasts (1.25 ng/ml). However, this effect is concentration dependent, as 
0.05 ng/ml of TNF-α has been shown to stimulate myoblast differentiation, while 0.5-5 
ng/ml are inhibitory (Chen et al., 2007). 
 
 
























1.5.3.3 Interleukin-6 (IL-6) 
IL-6, a pleiotropic cytokine, was first discovered by Weissenbach and others in human 
fibroblasts (Weissenbach et al., 1980). IL-6 is produced by a number of cells including: 
skeletal muscle cells under various conditions, adipocytes, macrophages, neutrophils, 
endothelial cells and osteoblasts (Akira et al., 1993, Corbel and Melchers, 1984, De 
Rossi et al., 2000, Heinrich et al., 1990, Nagaraju et al., 1998, Pedersen et al., 2001). 
Exercise rapidly increases the nuclear transcriptional rate of IL-6 within the contracting 
muscles, with a 10- to 20-fold increase in mRNA content observed following 30 
minutes of “non-damaging” exercise and a possible peak (up to 100-fold) immediately 
at the end of the exercise bout (Keller et al., 2001). Furthermore, The cytokine IL-6 is 
produced and release by muscle fibres into the circulation during exercise (Penkowa et 
al., 2003). At the membrane of target cells, IL-6 exerts its effect by binding to the 
membrane bound receptor α subunit (IL-6Rα) and association of the receptor with 
gp130 to trigger signalling transduction (Taga et al., 1989). Cellular effects are induced 
through the JAK/STAT pathway (Figure 1.9) (Heinrich et al., 1998, Ni et al., 2004). In 
response to IL-6 binding, JAK becomes activated which then activates and 
phosphorylates STAT3 at a Tyrosine residue at position 705. Two activated STAT3 
molecules will homodimerise and translocate to the nucleus to activate transcription. 
 
IL-6 is a pro-inflammatory cytokine and IL-6 infusion or over-expression in mice 
increases muscle atrophy (Bonetto et al., 2011, Strassmann et al., 1992, Tsujinaka et al., 
1995). Following 14 days of intramuscular infusion of IL-6, loss myofibrillar content 
and decreased total protein content have been observed in tibialis anterior in rats 
(Haddad et al., 2005). Furthermore, it has been observed that chronic IL-6 exposure on 
young animals can also slow the rate of muscle growth (Bodell et al., 2009). 
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In contrast to the previous finding, IL-6 knockout mice demonstrated a blunted 
hypertrophic muscle growth compared with wild-type mice as a result of reduced 
myonuclear number as well as satellite cells proliferation (Serrano et al., 2008). The 
ablation of IL-6 decreases the expression of myogenin in C2C12 myogenic cells, whereas 
the administration of IL-6 (2 ng/ml) markedly increases the expression of this protein 
(Baeza-Raja and Munoz-Canoves, 2004). A recent study reported that recombinant IL-6 
(10 ng/ml) promoted proliferation of human myoblasts (Wang et al., 2008). 
 
The contrasting effects of IL-6 on muscle remain to be explained, but one possibility is 
that endogenous levels produced during non-inflammatory situations are beneficial 
whereas when IL-6 is overproduced in scenarios where inflammation or other 

























Sarcopaenia is the age-related loss of muscle mass. Sarcopaenia is a prevalent condition 
which can contribute to a reduced quality of life and increased mortality risk in the 
elderly. Satellite cells are the muscle stems which are used in muscle maintenance, 
repair and hypertrophy. There is growing interest in the behaviour of these cells in 
regard to muscle ageing. Once removed from their anatomical location satellite cells 
(muscle precursor cells or myoblasts) can be studied in culture and repetitively passaged 
until they reach proliferative senescence (a state where they are no longer able to 
divide).  This approach has been used as a model of muscle ageing. However, there is 
uncertainty as to how in vitro ageing of cells reflects of the behaviour of these cells aged 
in vivo, i.e. when obtained from elderly people.  
 
Two models have been proposed to explain defective regeneration of aged muscles: 1) 
systemic factors impair satellite cell responses or 2) satellite cells themselves exhibit a 
decline in function with age. The overall aim of this thesis was to study the behaviour of 
human myoblasts in regard to their ability to proliferate and differentiate in vitro by 
obtaining cells from muscle biopsy samples from subjects of different ages and to 
examine the effects of senescence and age-associated inflammatory factors on these 








The work in this thesis therefore aims to test three main hypotheses: 
1- Myoblasts aged in vivo (obtained from old subjects) display a similar cellular 
phenotype to senescent myoblasts (aged in vitro) and these are distinct from that of 
myoblasts obtained from young subjects. (Chapter 3 and 4) 
2- Inflammatory cytokines inhibit proliferation and differentiation of human myoblasts 
in a dose dependent manner. (Chapter 5)   
3- Culture of human myoblasts in elderly human serum will inhibit proliferation of 
human myoblasts compared to culture in young human serum. (Chapter 6) 
 
To address my hypotheses the specific aims were of the thesis are listed below:  
1- To investigate differences between young and old myoblasts in term of their optimal 
proliferation and differentiation in vitro. 
2- To compare the differentiation potential of cells obtained from young and old people 
with those of cells that reached proliferative senescence (i.e. were “aged” in culture). 
3- To analyse the cytokine profile (secretome) of cells from young, old and senescent 
myoblasts during differentiation. 
4- To elucidate the role of aged-associated inflammatory cytokines in the behaviour of 
human myoblasts. 
5- To investigate the effects of young or old human serum to sustain or inhibit 
































This chapter describe the general techniques used, further specific details can be found 
within the relevant chapters.   
2.1 Human subjects and ethical approval 
All subjects gave written informed consent to take part in the studies reported in this 
thesis. Before inclusion, all experimental protocol was described to potential subjects in 
detail and time was allocated to allow for the individual to ask any questions that they 
may have had regarding any aspect of the study. Following this meeting, subjects were 
asked to completed a healthy questionnaire as defined by (Greig et al., 1994) and only 
healthy individuals were included in the study Ethical approval was given by the 
London Research Ethics Committee and all experimental procedures were performed in 
a Human Tissue Authority licensed laboratory in accordance with the Human tissue Act 
(2004) and the Declaration of Helsinki.  
 
2.2 Muscle biopsy procedure 
Muscle samples were obtained from the vastus lateralis muscle by using the needle 
muscle biopsy technique (Bergstrom, 1962). Briefly, subjects rested in a supine 
position. The skin overlaying the area to be sampled was shaved, if required, and 
thoroughly cleaned with chlorhexadine solution and then anaesthetised (2% lignocaine). 
After allowing a short time for the anaesthetic to take affect, a small scalpel blade was 
used to make a 0.5 cm incision through the skin and muscle fascia. A biopsy needle was 
then inserted through the incision into the muscle belly, and suction applied via a 50 ml 
syringe. Each biopsy provided 100-300 mg of muscle tissue and was immediately 
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placed in ice cold Solution A (7.2mg/ml HEPES, 7.6mg/ml NaCl, 224μg/ml KCl, 
1.98mg/ml D-Glucose, 1.134μg/ml Phenol red, ddH2O, pH 7.6; Sigma Aldrich).  
 
2.3 Blood sampling and serum extraction 
Following the biopsy procedure, blood (A maximum of 50ml) was drawn from an 
antecubital vein into a 10-ml serum vacutainer tube (BD vacutainer ref. 367958). After 
coagulating for 30 min at room temperature, the blood was centrifuged at 3000g for ten 
minutes. Serum was immediately pipetted off and divided into aliquots of one millilitre 
and stored at -70ºC. A fresh aliquot was subsequently thawed for each experiment.  
 
2.4 Cell culture 
All cell manipulations were performed in a positive pressure tissue culture hood. Prior 
and subsequent to each manipulation, the tissue culture hood surfaces were cleaned with 
1% Virkon solution followed by 70% ethanol.  
 
2.4.1 Satellite cell extraction 
The muscle biopsy material was moved into the sterile tissue culture hood and washed 
with Solution A to remove any surface blood. It was then stripped of visible connective 
and fat tissue using sterile scalpels and the remaining tissue was cut into pieces less than 
one millimetre in diameter on a petri dish containing 5ml ATE solution (solution A + 
5mg/ml Trypsin EDTA, Invitrogen). A wide bore pipette (25 ml) was then used to 
transfer the enzyme solution containing minced muscle, to a sterile 35 ml Wheaton flask 
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containing a magnetic stirrer. The dish was washed twice with 5ml ATE solution to 
collect any muscle fragments which were not aspirated on the first attempt, and placed 
into the flask making the total volume up to 15 ml. The muscle fragment suspension 
was heated in a stirring water bath at 37ºC for 15 min with gentle agitation to dissociate 
muscle cells. The supernatant containing suspended cells was aspirated and transferred 
to a sterile 50 ml falcon tube (BD Bioscience, Belgium) containing 15 ml DMEM 
(Invitrogen), 10% foetal calf serum (FCS) Gold (PAA) and 1% PSG (100 units/ml 
Penicillin, 100 μg/ml Streptomycin and 292 μg/ml L-Glutamine, Gibco). Fresh ATE 
solution (15ml) was added to the remaining muscle and the entire procedure repeated 
twice. The three supernatants were centrifuged for six minutes at 650g. Following 
centrifugation, the supernatant containing enzymes was discarded and the cell pellet was 
re-suspended in skeletal muscle growth medium (Promocell, Germany; containing 50 
µg/ml Foetal Calf Serum (FCS), 50 µg/ml Fetuin (bovine), 10 ng/ml Epidermal Growth 
factor, 1 ng/ml Basic fibroblast Growth Factor, 10 µg/ml insulin and 0.4 µg/ml 
Dexamethasone) supplemented with 10% FCS and PSG (100 units/ml Penicillin, 100 
μg/ml Streptomycin and 292 μg/ml L-Glutamine) or basal medium (Promocell, 
Germany). At this point in the procedure the cells are referred to as freshly isolated 
cells.   
 
2.4.2 Estimation of cell viability 
A Neubauer haemocytometer was used in order to make an estimate of viable cell 
number, 10 µl of well mixed cell suspension, 4 µl of 0.5% trypan blue and 6 µl of 
skeletal muscle growth medium were mixed in a sterile 1.5ml microcentrifuge tube. The 
solution was placed in the cell incubator (37
o
C, 5% CO2) for 5 min. 10 µl of this 
 66 
 
solution were loaded into the haemocytometer. Cells in the four corner grids were 
counted under a Nikon model inverted microscope at x 100 magnification. Viable cells 
identified as iridescent, with rounded morphology. Non-viable cells lost their membrane 
integrity and hence were trypan blue positive. The resultant mean of 4 grids was 
calculated, which represented average cell numbers occupying 0.1 mm
3
. The percentage 
of viable cells was calculated as: 
        % viability = (number of viable cells counted/ total number of cells counted) x 100 
The total number of cells was calculated as: 
        Cells.ml
-1 






2.4.3 Expansion of freshly isolated cells 
Freshly isolated cells resuspended in GM were transferred to sterile T75 flask. Cells 
were cultured in a humidified incubator at 37ºC and 5% CO2. The medium was 
refreshed on the third day after the extraction procedure and subsequently every 48 
hours. Cells were passaged every 48-96 hours depending on when they reached 50% 
confluence as described in Section 2.4.4. The cells were expanded for two weeks and 
frozen in liquid N2. Cells that were cultured for two weeks, stored in liquid nitrogen and 
thawed are referred to in this thesis as committed myoblasts.   
  
2.4.4 Passaging procedure 
Cells were passaged every 48-92 hrs or at 50% confluence. Culture medium was 
removed and placed in a 50 ml Falcon tube. The flask was then gently washed twice 
with warmed (37°C) Phosphate buffer saline (PBS, Invitrogen) to remove any serum, 
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and this solution also added to the 50 ml tube. To enzymatically detach cells from their 
culture flask, a pre-warmed (37°C) solution of 5mg/ml trypsin EDTA (Sigma) in PBS 
was added and the flask was transferred to the incubator for 2-5 mins. Dissociation of 
the cells from the base of the flask was checked under the microscope, if necessary flask 
was gently tapped to facilitate cell release. The cells were then transferred to the 50 ml 
tube containing used media and PBS. The cell suspension was centrifuged (6 mins at 
650g) and the cell pellet was resuspended in a volume of GM or basal medium. A small 
volume (10µl) was removed to check the total cell number and viability (Section 2.4.2).  
 
2.4.5 Thawing procedure 
Growth medium was placed in vented T75 flasks. Flasks were incubated in the cell 
culture incubator for 30 minutes. Following removal from liquid nitrogen tanks, cell 
vials were immediately placed in a water bath at 37°C and allowed to thaw as quickly as 
possible. Vials were cleaned with 70% ethanol and transferred to the culture hood. A 
small amount of pre-warmed growth medium was transferred from the flask to the 
cryovial containing the cells and the liquid was gently aspirated. All medium from the 
cryovial was added dropwise into the tissue culture flask and the cell suspension mixed 
gently. The flask was placed in the incubator and monitored for cell adherence over the 
next 24 hours.  
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2.5 experiment with freshly isolated cells 
2.5.1 Culture of cells in human serum 
Freshly isolated cells were resuspended in basal medium. Cells were plated in duplicate 
wells of a 24 well plate, coated with ECM matrix (8 mg/ml, Sigma), at a density of 
100,000 cells per well. To each well was added an equal volume of 2X GM containing 
all supplements at twice the working concentration described in section 4.2.1 or of basal 
medium supplemented with 30% human serum and 2% PSG. This resulted in final 
serum and antibiotic concentrations were halved and were at the appropriate working 
concentrations. Media were changed 72 hours after initial isolation and every 48 hours 
thereafter. Before discarding, old media was transferred to a sterile 1.5ml 
microcentrifuge tube and centrifuged at 650g for six minutes to harvest any floating 
myoblasts. The supernatant was discarded and the cell pellet was re-suspended in fresh 
medium and added to the appropriate culture wells. Cells were fixed at 3, 5 and 7 days 
after isolation. 
 
2.5.2 Culture with human recombinant cytokines 
Freshly isolated cells were resuspended in basal medium. Cells were plated in duplicate 
wells of a 24 well plate, coated with ECM matrix (8 mg/ml, Sigma), at a density of 
100,000 cells per well. Equal volumes of 2Х GM (control) or 2Х GM supplemented 
with twice the desired final cytokine concentration and 2% PSG were then added to 
each well such that final cytokine, serum and antibiotic concentrations were halved. For 
differentiation assays on freshly isolated cells, three days after plating in GM “at this 
time cells appear attached to the plates” as described above the medium was aspirated 
and replaced with differentiation medium (DM), the skeletal muscle cell basal medium 
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supplemented with 0.5% BSA and 1% PS (100 units/ml Penicillin, 100 μg/ml 
Streptomycin) and no cytokines (control) or with 1 ng.ml
-1
 TNF-α, TGF-β or IL-1β. 
Media were changed every 48 hrs. Before discarding, old media was transferred to a 
sterile 1.5ml eppendorf tube and centrifuged at 650g for six minutes to harvest any 
floating myoblasts. The supernatant was discarded and the cell pellet was re-suspended 
in fresh medium and added to the appropriate culture wells. Cells were fixed after 7 
days in differentiation medium.  
 
2.6 Committed human myoblast culture 
After thawing (Section 2.4.5), cells in this thesis are referred to as committed myoblasts. 
The cells were cultured in GM and the medium was changed every 48 hrs. Once the 
cells were 50% confluent after a total of 48-92 hrs, they were counted passaged once 
(Section 2.4.4) and divided for experimental procedures as outlined below. 
 
2.6.1 Population Doubling Time 
The cells were cultured in growth medium as described above. Media was replaced with 
fresh GM every 2 days. Cells were passaged as described in section 2.4.4 at 50% 
confluence. Cell pellet was resuspended in GM and counted as described in section 
2.4.2. For population doubling experiments cells were plated at a density of 2.5 Х 103 
cells/cm
2 
in 35mm culture dishes in triplicate. The number of population doubling at 
every passage was calculated as PD = log (N1/N0)/log2 where N1 is the final cell number 
and N0 is the initial number of cells seeded. Proliferative senescence was defined as 
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failure of cells to divide for three consecutive weeks (Bigot et al., 2008, Di Donna et al., 
2003). 
2.6.2 Proliferation and differentiation assays 
Cells were passaged once (Section 2.4.4) and cultured in GM to 50% confluence. At 
this point, cells were plated in 96 well dishes at a density of 1000 cells/well. Cells were 
fixed after 24 hr and different antigens were examined by immunocytochemistry 
(Section 2.8). For differentiation assays, cells were plated in duplicate in 96 well dishes 
at a density of 7000 cells/well. Media was replaced after 24 hr with differentiation 
medium (DM), containing basal medium supplemented with 10 µg/ml insulin (Sigma), 
10 µg/ml transferin (Sigma) and 1% PS (100 units/ml Penicillin, 100 μg/ml 
Streptomycin). Cells were cultured for a further 7 days in differentiation medium, with 
aliquots of cells being fixed every 24 hr. 
 
2.6.3 Collection of conditioned media 
At early passage (young and old cells) and late passage (senescent cells), aliquots of 
7000 cells were plated into a 96 well dishes in growth medium. After 24 hr, 
differentiation was induced by simply replacing growth medium with differentiation 
medium. Conditioned media (CM) were collected after two 48 hour incubation periods 
after placing the cells in DM: The period between day 0- and day 2 of differentiation 
(i.e. the first 48 hours in DM) and between days three and five of differentiation (i.e. 72-





2.7 Reconstitution of cytokines 
10 µg recombinant human TNF-α (Calbiochem, Nottingham, UK) was purchased and 
initially prepared as x 1000 stock solution at 100 ng.µl
-1
 TNF-α containing sterile 
distilled water. It was stored at -20ºC until required.  
 
Recombinant human TGF-β was purchased from R&D systems, Inc. The 2 µg pellet 
was reconstituted in 20 µl of sterile HCL making the stock solution concentration of 
0.10 µg. µl
-1
. It was stored at -20ºC until required.  
 
Recombinant human IL-1β, IL-6 and IL-8 were purchased from R&D systems, INC. 
The 5 µg pellet was reconstituted in 50 µl of sterile PBS making the stock solution of 
0.10 mg/ml. It was stored at -20ºC until required. 
 
2.8 Immunocytochemistry 
2.8.1 Fixation procedure 
At the end of all experiments, cells were fixed in their wells by the addition of an equal 
amount of 2X PFA medium (7.4% paraformaldehyde +/- 0.4% Triton) to the 
experimental culture medium for 10 mins. The fixative and medium were then aspirated 
off and the wells were washed 2Х for 5 mins with PBS/0.01%NaN3 to remove any 




2.8.2 Immunocytochemistry procedure 
After fixation cells were incubated in blocking solution, 1% bovine serum albumin 
fraction V ≥ 96% (BSA; sigma) in PBS, 0.01% NaN3 for one hour at room temperature. 
The primary antibodies used and their working dilutions are described in detail in table 
2.1. Primary antibodies were diluted in 1% BSA and incubated overnight at room 
temperature. Wells were washed 2Х for 5min in PBS/NaN3, and then incubated for 1hr 
at room temperature in appropriate secondary antibody (diluted 1:1000 in 1% BSA). 
Wells were washed 2Х for 5mins in PBS, 0.01% NaN3. Nuclei were stained by 
incubating for 10 mins in 1μg/ml Hoechst 33258 solution (Sigma). 
 
Secondary antibodies were Alexa fluor 594 goat anti-rabbit, Alexa flour 594 goat anti- 
mouse and Alexa fluor 488 goat anti-mouse (Invitrogen). 
 
2.8.3 Analysis  
All samples were blinded and coded to the investigator. Images of at least five randomly 
selected fields of view were selected and photographed using a digital camera mounted 
to a Zeiss Axiovert 135 inverted fluorescence microscope at 10 or 32X objectives. A 
grid system was used to avoid re-sampling of a counted area. Two wells were studied 
per condition and the mean value used for analysis. At least 250 nuclei within each field 







Table 2.1. Primary antibodies used 
Clone name 
 
Supplier Dilution Antigen Recognise 








MF20 Developmental Studies 
Hybridoma Bank 
 
1:100 Sarcomeric MHC 
NCL-MyoD1 Novocastra Laboratories 
(UK) LTD 
1:50 MyoD1 





























2.9 Luminex based assays 
The Luminex assay was employed to investigate concentration of cytokines, 
chemokines and growth factors in serum and in conditioned media. This multiplex 
immunoassay is based on xMAP® detection technology, combining a flow cytometer, a 
fluorescent-dyed beads, lasers and digital signal processing. The assay was prepared and 
used according to the manufacturer’s protocol using High Sensitivity Human Cytokine 
Magnetic Bead (cat. # HSCYTMAG-60SK, Millipore) and TGF-β1 Single Plex (cat. # 
TGF-β-64K-01, Millipore).  
 
The principle of this technology is the ability to measure several proteins 
simultaneously in a single sample (Figure 2.1). Microspheres are identified by loading 
them with different concentrations of two fluorescent dyes. Different antibodies are 
linked to the surface of microspheres with a particular identity. The microspheres are 
first incubated with the sample, then biotin conjugated secondary antibodies and finally 
streptavidin-conjugated phycoerythrin (Figure 2.1). The instrument (FLEXMAP3D) 
works much like a flow cytometer and focuses the beads into a stream where they pass 
two lasers in single file. One excites the dyes with which the microsphere were loaded 
identifying the bead and thus the antibody bound to it, and the second excites the 
phycoerythrin and allows quantification of the bound antigen. Colour signal is captured, 
translated digitally into real time and the data is then quantified. The technology has the 












   
 
  Figure 2.1. Basic Principle of Luminex Assay.  
Adapted from www1.ic.ac.uk/resources. 


















1. An aliquot of culture supernatant or serum was thawed prior to the experiments.  
2. Standards were prepared by serial dilution according to the manufacturer’s protocol.  
3. The filter was pre-wet by pipetting 200 µl of 1X Wash Buffer into each well of either 
Microtiter Filter Plate or Magnetic plate. 
4. The plate was sealed and mixed on a plate shaker for 10 minutes at room temperature. 
5. Washing buffer was removed by vacuum (filter plate) or aspiration with a 
multichannel pipette (Magplates).  
6. The bead bottle was sonicated for 30 seconds and vortexed for 1 minute. 
7. 25 µl of the mixed beads were added to each well. 
8. 25-50 µl of assay buffer were added to the background and the sample wells 
depending on the kit. 
9. Equal volumes (25-50 µl depending on the kit) of each sample, standard and control 
were added to appropriate wells. 
10. Where serum was being measured, 25-50 µl of matrix solution were added to the 
background, standards, and controlwells. 
11. The plate was covered with aluminium foil and incubated with agitation on a plate 
shaker overnight at 4ºC. 
12. The fluid was removed by vacuum aspiration aspiration with a multichannel pipette 
(Magplates). 
13. The plate was washed with 200 µl washing buffer two times.  
14. 25-50 µl of detection antibody was added to each well. 
15. The plate was sealed with aluminium foil, and incubated on a plate shaker for one 
hour at room temperature. 
16. 25-50 µl Streptavidin-Phycoerythrin was added to each well. 
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17. The plate was covered with aluminium foil, and incubated with agitation on a plate 
shaker for 30 minutes at room temperature. 
18. The content was removed by vacuum aspiration with a multichannel pipette 
(Magplates).  
19. The plate was washed with 200 µl washing buffer two times. 
20. 100-150 µl of sheath fluid was added to each well. The plate was covered with 
aluminium foil and resuspended the beads on a plate shaker for five minutes. 
20. The plate was read.  
2.10 Measurement of myotube area  
Myotubes were measured using Adobe Photoshop Cs version 8 as described by Agley et 
al. (2012). It must be noted that the image analysis of myotube area was a surrogate 
based on MHC expression. In brief, digital images of MHC stained cells were taken 
from five non-overlapping fields per well using Zeiss Axiovert 135 inverted 
fluorescence microscope at 10 X objective. Scale bars were inserted into every image 
and the files were saved in Tiff format. Without re-sizing the image, the measuring tool 
was used to measure the number of pixels spanning the scale bar. By dividing the 
known linear distance of the scale bar (100 µm) by the pixel value, individual pixel 
width in µm was obtained. As pixels are perfect squares, multiplying the width of a 
single by itself (pixel height) will give its area in µm
2
. This calibration factor was 
entered into an excel spreadsheet. The myotube area was selected based on MHC 
staining, using the colour range select panel. The number of pixels corresponding to this 
area was then quantified with histogram function. This pixel value was entered into the 
excel spreadsheet and multiplied by the calibration factor to yield a close approximation 





2.11 Evaluation methods used 
Several different methods of myoblasts extraction have been used for human muscle. 
Generally satellite cells are extracted by the explants or digestion methods. The 
digestion method protocol used in this thesis involves the incubation of muscle 
fragments with the digestive enzymes trypsin (Morgan; eurobiobank 2004). This help to 
dissociate the mononucleated satellite cells from their associated myofibres. Two pilot 
experiments were performed in order to see which medium and coating conditions were 
suitable for the extraction of muscle cells from biopsy tissue.  
1- Cell expansion was compared using Ham F-10 (Invitrogen) or DMEM (Invitrogen) 
or Promocell to see which medium suitable for muscle cells, cells were assessed for 
their time to 50% confluence and total cell yield (Table 2.2). Promocell medium 
produced the highest yield of cells and were the first to reach 50% confluency.  
 
2- ECM matrix coating condition was compared with plastic (uncoated) plates in order 
to see whether ECM matrix suitable for the attachment of muscle cells extracted from 
muscle biopsy (Table 2.3). This experiment indicates that ECM matrix coated dishes 
were adequate in promoting the attachment of muscle stem cells compared to uncoated 
dishes.  
 
Both Promocell medium and ECM coated dishes will be used in future experiment.  
 
β-galactosidase assay (Millipore) was used as described in Dimri et al. 1995 to define 
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Chapter 3: Senescence, but not in 
vivo ageing, is associated with 
delayed differentiation and 














The serial passaging of normal somatic cells ultimately results in a state of permanent 
growth arrest called replicative senescence. This was initially shown for fibroblasts by 
Hayflick and Moorhead (1961) but also more recently, for human satellite cells (Decary 
et al., 1997). The senescing myoblasts have been used as a model to study muscle 
ageing. For example, senescent myoblasts obtained from an infant donor showed a 
delayed differentiation response compared to proliferating myoblasts from the same 
donor (Bigot et al., 2008). Serially passage C2C12 cells in vitro exhibited a reduced in 
MyoD and myogenin expression which are associated with decreased IGF expression 
(Sharples et al., 2011). However, there is uncertainty as to how in vitro ageing of cells 
reflects the physiological process of ageing of similar cells in vivo, e.g. when 
proliferating cells obtained from young and elderly subjects are compared.  
 
Satellite cell activation and proliferation have been shown to be impaired in older 
animals in response to injury and represents one of the key age-specific defects in 
muscle repair (Conboy et al., 2003, Scime et al., 2009). There is also some evidence that 
myoblasts obtained from muscles of elderly people do not differentiate as efficiently in 
vitro when compared with those from younger subjects (Beccafico et al., 2007, 
Beccafico et al., 2010, Jacquemin et al., 2004, Lorenzon et al., 2004, Pietrangelo et al., 
2009). Critically, these conclusions are drawn from comparison of very limited numbers 
of subjects, often only one from each age group (Jacquemin et al., 2004, Lorenzon et al., 
2004), and from populations that often have a low proportion of myoblasts (Pietrangelo 






There were two aims to the study presented in this chapter. The first was to examine 
differences between myoblasts obtained from young and old people in terms of their 
proliferation and differentiation in vitro. The second was to compare the behaviour of 




The methods for myoblast extraction are detailed in the general methods chapter 
(Section 2.4.1), as are methods for expanding, storing, thawing, culturing, calculating 
population doubling time and passaging (Section 2.4 and 2.6). Measurement of myotube 
area was carried out as described in Section 2.10.  
 
3.3.1 Subjects 
Prior to acceptance in the study, participants completed a health questionnaire and were 
only included if they fulfilled the “healthy” or “medically stable” criteria (Greig et al., 
1994). The total muscle biopsies were collected from 5 young (aged 23-25 years) and 4 





3.3.2 Culturing human myoblasts 
Following thawing, cells were cultured in a skeletal muscle cell growth medium (GM) 
until they reached senescence (defined as failure to divide for three consecutive weeks). 
The proportion of desmin (myoblasts) and Ki67 (proliferating) positive cells over time 
in culture was monitored. At several time points during the culture period (4, 16, 28 
days and when the cells reached senescence) cells were monitored for expression of 
MyoD (myogenic regulatory factor involved in the specification and activation of 
satellite cells) and differentiation potential. For differentiation experiments, cells were 
plated in 96 well dishes at a density of 7000 cells/well. GM was replaced after 24 hours 
with a differentiation medium (DM) and cultured for a further 7 days in DM, with 
aliquots of cells being fixed every 24 hours in 4% paraformaldehyde + 0.2% triton. 
Cells expressing markers of differentiation (myogenin and myosin heavy chain, MHC) 
were identified using immunocytochemistry as described in chapter 2 (section 2.8). 
Fusion index was measured after 7 days and expressed as the percentage of nuclei in 
myosin heavy chain positive cells containing at least two nuclei. 
 
3.3.3 DNA damage staining 
Aliquots of cells (1000 cells) from non-senescent and senescent populations were plated 
into 96 well dishes in growth medium. The cells were fixed after 24 hrs with 4% 
paraformaldehyde + 0.2% triton and stained for γ-H2AX (DNA damage marker). 
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3.4 Statistics  
Statistical comparisons were made using IBM SPSS 19 software, and P values ≤ 0.05 
were considered significant. Statistical significance for interactions between groups 
(Young, Elderly, 16 days, 28 days and Senescent) and time was determined using mixed 
two-way repeated measure analysis of variance (ANOVA) with post-hoc Bonferroni. 
One-way ANOVA with post-hoc Tukey comparisons was conducted to confirm 
statistical significance between variable of interest e.g. between groups. Results for 
repeated measure and one-way ANOVA are expressed using the F-Ratio Data are 
representative of three experiments performed in duplicate. All values are shown as 
individual data points or as mean values ± SE. T-tests were used when comparing 
young and elderly cells with a single condition. ANOVA was used when performing 




3.5.1 Desmin content of young and elderly subjects 
The percentage of desmin positive cells was evaluated in myoblast populations obtained 
from frozen stocks of early passage primary cultures obtained from biopsies of five 
young and four elderly subjects. Representative images of desmin and Ki67 are shown 
in Figure 3.1. The cell preparations used here were similar in terms of the desmin 
expression (Table 3.1). The data showed no aged related differences in cultures obtained 




3.5.2 Replicative potential and desmin content of human myoblasts 
over time in culture. 
To compare the proliferative potentials and desmin content of myoblasts isolated from 
young and old muscle biopsies. Cells were continually passaged in growth medium until 
they reached replicative senescence. This was defined as failure to divide for three 
consecutive weeks. Upon thawing and expansion, the samples behaved in a similar 
manner irrespective of the age of the donor: Several populations of cells (two from 
young subjects and three from elderly subjects) maintained their initial desmin content 
(50-94%) over time in culture (Figure 3.2a) and underwent 5-12 mean population 
doublings (MPDs; C, E, F, G and H, Figure 3.3). Others populations, however, lost their 
desmin content over time (50-95% starting, 0% at senescence; Figure 3.4a) and 
underwent 15-20 MPDs (A, B, D and I, Figure 3.1). Cells that did not maintain desmin 
content were discarded from analysis of γ-H2AX, MyoD and differentiation (Section 
3.5.4-3.5.7). 
 
        Table 3.1. Percentage of desmin positive cells in young and old subjects. 
                  

































Figure 3.1. Images taken from of (a) young (from a male subject aged 20), (b) elderly 
(from a male subject aged 77) and (c) senescent myoblasts stained for desmin (green), 
Ki67 (red) and Hoechst 33342 (blue) after 24 hours in growth medium. Scale bar = 20 
µm. Young and elderly cells were similar in term of desmin and Ki67 expression. 
Senescent cells display a larger and more flattened morphology with an increased in 


































Days in culture 
Desmin 
A 23 yr 
B 20 Yr 
C 82 yr 
D 80 yr 

























































Days in culture 































Figure 3.2. Time course of (a) Desmin, (b) Ki67 and (C) Desmin+Ki67 expression for 
cells that maintained desmin, in human myoblasts obtained from young (n=2) and 
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Figure 3.3. In vitro expansion of human satellite cells isolated from subjects of different 
ages. The number of population doubling at every passage was calculated as PD = log 
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Figure 3.4. Time course of (a) Desmin, (b) Ki67 and (C) Desmin+Ki67 expression for 
populations that lost desmin. Cells were obtained from three young subjects and one 
elderly subject over time in culture. 
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3.5.3 Myoblast proliferation from young and elderly subjects. 
The relative proportion of Ki67
+ve
 cells measured 24 hours after plating was similar 
between cells obtained from young (55.8 ± 2.9%) and elderly (54.8 ± 3.3%) individuals 
(Figure 3.5a). The percentage of proliferating muscle cells (Ki67 and desmin positive) 
was also similar between cells obtained from young (47.8 ± 5%) and elderly (54.8 ± 
3.3%) subjects after 24 hours in growth medium (Figure 3.5b). Upon serial passaging of 
cells that maintained desmin over time, the proportion of proliferating muscle cells 
decreased gradually until the cells finally stopped proliferating after 28 to 35 days. 
Although there was some heterogeneity between populations (Figure 3.2c), this was the 
case in both young and elderly individuals and no age related differences are apparent. 
The time course of Ki67 expression in cells that lost desmin expression is shown in 
Figure 3.4 b and c. Again there was some heterogeneity between populations and no 
apparent age effect, although there was only one cell population from an elderly subject 
in this group. It can be seen by comparing Figure 3.3 that populations that lost desmin 
had longer proliferative potentials and this was reflected in their expression of Ki67 
(Figure 3.2b and 3.4b).  
 
3.5.4 Expression of MyoD in growth medium from young and elderly 
myoblasts compared to in vitro ageing. 
After 24 hr culture in GM, MyoD expression was found to be similar between cells 
obtained from young and elderly donors (8.6 ± 2.1%, young vs. 7.8 ± 1.31%, old; 
Figure 3.6). After this initial analyses the two young and three old cell populations that 
maintained desmin expression were analysed as a group of n=5 populations. There was 
























































(i.e. after 16 and 28 days in culture) but the difference from young and old cells only 


















Figure 3.5. Similar proliferation in young and old human myoblasts.  
Myoblasts from young (n=5) and elderly (n=4) subjects were cultured in growth 
medium for 24 hr and stained for desmin and Ki67. No significant differences were 





















































Figure 3.6. Changes in MyoD expression with time in culture, in human myoblasts 
obtained from young (n=5) and elderly (n=4) subjects analysed 24 hours after plating. 
Thereafter, young and old cells were analysed as a group (n=5) after 16 and 28 days and 
when they reached replicative senescence. Only when the cells reached senescence was 
there a significant reduction in the expression of MyoD compared to young and elderly 
cells. *, P = 0.02 statistically significant difference from young and elderly subjects. 
Data are mean value ± SE. 
 
 









3.5.5 Myoblast differentiation from young and elderly subjects 
compared with in vitro ageing. 
Figure 3.7 shows representative images from young and elderly biopsies of 
myogenin+ki67 expression. Typical staining patterns of myogenin and MHC+MyoD 
are shown in Figure 3.8 & 3.9.  
 
Figure 3.10a shows quantitation of expression of myogenin and Ki67 in the populations 
that maintained desmin over time in culture. A significant proportion of myogenin+ve 
cells were also Ki67+ve after 24 (day 1) and 48 hours (day 2) in differentiation medium 
(DM). This was the case in both the young and elderly myoblasts, indicating that 
myoblasts are capable of expressing myogenin before complete cell cycle arrest. 
 
Myoblasts derived from young and elderly subjects expressed MyoD in proliferation 
medium (Figure 3.6 and Figure 3.11b). Myogenin expression was apparent within 24 
hours of change to differentiation medium (Figure 3.10b) and preceded MHC 
expression which was only detected after 48 hours of differentiation (Figure 3.11a). All 
MHC 
+ve
 cells were also MyoD 
+ve
. Interestingly, at the onset of fusion (day 3 of 
differentiation), all MyoD 
+ve
 nuclei were found within MHC 
+ve
 myotubes (Figure 
3.11c). There was a delay in the onset of myogenin and MHC expression (Figure 3,10b 
& 3.11) when cells reached senescence.    
 
The proportion of cells expressing MyoD, myogenin, MHC and co-staining for both 
MHC and MyoD significantly increased during differentiation, F (1, 19) = 843, P < 
0.0005 for myogenin, F (1, 19) = 1396, P < 0.0005 for MHC, F (1, 19) = 638, P < 0.0005 for 
MyoD, F (1, 19) = 1396, P < 0.0005 for MHC and MyoD co-staining.  
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No significant differences were observed in the percentage of MyoD+ve , 
myogenin+ve, Ki67+ve/myogenin+ve , MyoD +ve/MHC+ve and MHC+ve cells 
between young and elderly myoblast at any point during differentiation.  
 
Cells cultured for several passages and examined 16 and 28 days after thawing showed 
a significant and progressive decrease in the percentage of MyoD
+ve
 (F (4, 19) = 133, P < 
0.0005), myogenin
+ve




 (F (4, 19) = 112, P < 
0.0005), and MHC
+ve
 (F (4, 19) = 112, P < 0.0005), cells at each time point during 
differentiation (Figure 3.10b & 3.11) and shown there was a significant interaction 
between groups and time.  
 
3.5.6 Fusion index and myotubes size of young and old cells compared 
with senescent cells. 
Seven days after differentiation was induced in the cells, fusion index (FI) and size of 
myotubes were determined. Myotube size was measured by quantitating the area in each 
field of view positive for MHC.  
 
The data presented in Figure 3.12a show that there was no difference in the FI between 
cells from the young and elderly subjects (88.8 ± 2.1%, young vs. 84 ± 1.9%, old). 
However, in the senescent cells the FI was significantly lower compared to cells from 





The data presented in Figure 3.12b shows that there was also no difference in myotube 
area between young and elderly cells at the earliest passage, but myotube area was 
significantly decreased in the senescent cells, F (1, 11) = 9.11, P = 0.005. Representative 















Figure 3.7. Images taken from of (a) young (from a male subject aged 23) and (b) 
elderly (from a male subject aged 80) stained for myogenin (yellow arrow), 
Ki67+Myogenin (green arrow) and Hoechst 33342 (white arrow) at 2 days in 
differentiation medium. Scale bar = 20 µm. A significant proportion of myogenin+ve 
cells were also Ki67+ve after 24 (day 1) and 48 hours (day 2) in differentiation medium 






































Figure 3.8. Images taken from of (a) young (from a male subject aged 23), (b) elderly 
(from a male subject aged 80) and (c) senescent myoblasts stained for myogenin 
(yellow arrow) and Hoechst 33342 (white arrow) at 7 days in differentiation medium. 
Scale bar = 20 µm. Young and elderly cells were similar in term of myogenin 
expression. There was a decrease in the onset of myogenin expression when cells 












































Figure 3.9. Images taken from of (a) young (from a male subject aged 25), (b) 
elderly (from a male subject aged 80) and (c) senescent myoblasts stained for 
MyoD+MHC (yellow arrow) and Hoechst 33342 (white arrow) at 7 days in 
differentiation medium. Scale bar = 20 µm. Young and elderly cells were similar 
in term MHC and MyoD expression. There was a decrease in the onset of MHC 














































































































Figure 3.10. Time course of (a) ki67+myogenin and (b) myogenin expression, in 
human myoblasts obtained from young (n=5) and elderly (n=4) subjects. Cells were 
either differentiated at early passage (in vivo ageing model) or at several time points 
during the culture period (16 and 18 days, n=5) until they reached replicative 
senescence (n=5). Data are mean value ± SE. *, P < 0.0005 statistically significant 






















































































































































Figure 3.11. Time course of (a) MHC,  (b) MyoD and (c) MyoD+MHC expression, in 
human myoblasts obtained from young (n=5) and elderly (n=4) subjects. Cells were 
either differentiated at early passage (in vivo ageing model) or at several time points 
during the culture period (16 and 18 days, n=5) until they reached replicative 
senescence (n=5). Data are mean value ± SE. *, P < 0.0005 statistically significant 













































Figure 3.12. Fusion index (a) and measurement of myotube total area (b), in human 
myoblasts obtained from young (n=5) and elderly (n=4) subjects. Cells were either 
differentiated at early passage (in vivo ageing model) or when they reached replicative 
senescence (n=5). Data are mean value ± SE. *, P < 0.0005 & **, P = 0.005 statistically 




















































Figure 3.13. Images taken from of (a) young (from a male subject aged 24), (b) elderly 
(from a male subject aged 82) and (c) senescent myoblasts stained for MHC (yellow 
arrow) and Hoechst 33342 (white arrow) at 7 days in differentiation medium. Senescent 
myoblasts were thinner and contain few myonuclei compared to the ones derived from 






3.5.7 DNA damage. 
Analysis of γ-H2AX (DNA damage Marker) expression in young and elderly myoblasts 
revealed very few positive cells in either the young or elderly myoblasts analysed at the 
earliest point in the culture (<10%, Figure 3.14, 3.15). In senescent cultures, 90% of 
myoblasts stained positive for γ-H2AX (Figure 3.15). These differences were 

















Figure 3.14. Images taken from of (a) early passage (white arrow) and (c) senescent 
myoblasts (yellow arrow) stained for γ-H2AX (red) and Hoechst 33342 (blue) after 24 
hours in growth medium. Scale bar = 20 µm. A markedly higher number of senescent 
cells were positive for γ-H2AX (a marker of DNA double strand breaks) compared to 


















































Figure 3.15. A DNA damage in senescent cells vs. early passage cells, in human 
myoblasts obtained from young (n=5) and elderly (n=4) subjects. Cell were either 
stained with γH2AX at early passage or when they reached replicative senescence 
(n=5). Data are mean value ± SE. *, P < 0.0005 statistically significant difference from 













Skeletal muscle regeneration and repair during life depends on the proliferation and 
differentiation of satellite cells. Any age-related changes in regenerative capacity 
intrinsic to the satellite cells themselves could thus be due to impaired proliferation or 
differentiation. This study revealed two main findings. Firstly, proliferative potential, 
differentiation potential and differentiation time course were similar between cells from 
the young and elderly subjects at the earliest passage analysed. The second major 
finding was that there was a progressive decrease in the ability of cells to express 
markers of differentiation with increasing time in culture. When the cells reached 
senescence, expression of myogenin and MHC was delayed by two-four days following 
transfer to differentiation medium when compared to early passage cells. In addition, a 
markedly higher number of senescent cells were positive for γ-H2AX (a marker of 
DNA double strand breaks) compared to early passage cells.  
 
3.6.1 Young vs. old myoblasts 
Marked heterogeneity in proliferation potential and desmin content was found in 
myoblasts obtained from different subjects, even when these are of the same age group. 
There does not appear to be a relationship between myogenic purity (proportion of 
desmin positive cells) of a population and the age of the donor which is in agreement 
with findings of others (Beccafico et al., 2007, Pietrangelo et al., 2009, Schafer et al., 
2006). Furthermore, there was no clear association between MPD and donor age. A 
replicative lifespan of 5-20 MPD observed for young and elderly myoblasts in this study 
is consistent with previous estimates of the replicative capacity for human myoblasts. 
Decary et al. (1997) observed replicative capacity of 6-19 population doublings for 
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young and elderly human myoblasts in culture, and Pietrangelo et al. (2009) reported 
that young and elderly human myoblasts reach senescence after 15-20 population 
doublings. Expression of markers of proliferation decreased gradually until the cells 
finally stopped proliferating. Other investigators who have found a progressive declined 
in the number of proliferating cells with time in culture (Renault et al., 2000).  
 
Several populations of cells maintained their initial desmin content whereas others lost 
their desmin content over time in culture. The results are in agreement with an earlier 
observation in human myoblasts showing that the number of population doubling and 
desmin expression varies independently of age (Schafer et al., 2006). Recent research 
has demonstrated that primary muscle precursor cells can be stratified into distinct 
populations based on their proliferative characteristics (Rossi et al., 2010, Rouger et al., 
2004). This finding is relevant to the study of human primary muscle cultures where it 
is possible that the balance of fast proliferating to slow proliferating muscle precursor 
cells may ultimately determine culture purity in the presence of contaminating 
fibroblasts. Fast proliferating cells may outstrip the growth of fibroblasts, or whereas 
slow proliferating may be outgrown by them.  
 
Many experiments support the finding that proliferation and differentiation of human 
muscle precursor cells are not affected by the age of the donor. Recent in vitro 
experiments show that muscle precursor cells obtained from elderly animals can 
proliferate and differentiate similarly to that of young animals (Dumke and Lees, 2011). 
Furthermore, it has been shown that human myoblasts from an elderly donor can 
contribute myonuclei very efficiently to regenerating mouse muscle in vivo (Schafer et 
al., 2006). Single fibre grafting experiment have shown that satellite cells from old 
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animal can possess an equivalent in vivo myogenic and self-renewal potential to that of 
young animals (Collins et al., 2007). Whole muscle grafting experiments have shown 
that although there is a slight delay in myotube formation, no difference is observed 
between elderly and young muscle grafted into elderly or young animals (Smythe et al., 
2008).   
 
In contrast to the present results and to the observations discussed above, other studies 
have found age associated difference when compare differentiation of primary human 
cells from donors of different ages. Lorenzon et al. (2004) compared human muscle 
cells obtained from a 2 year old, 21 year old, 48 year old and 76 year old. They found 
fusion index and number of nuclei per myotube were decreased between the 21 and 76 
year old subjects after 4, 6 and 9 days in culture (Lorenzon et al., 2004). There was also 
a delay in the maturation of the excitation-contraction coupling mechanism when 
myoblasts from the elderly donor were compared to those from the young donors 
(Lorenzon et al., 2004). Fulle et al. (2005) compared human muscle cells obtained from 
a newborn (5 day old), young (29 years old) and old (71 years old) subjects with 85, 71 
and 47% of desmin cells respectively. They found that the percentage of MHC positive 
cells (Fusion index) had decreased in the elderly subject after 5 days in culture when 
compared to newborn and young subjects. Subsequent experiments by this group have 
shown a 20% decrease of fusion index (as measured after 7 days of in vitro 
differentiation and expressed as the percentage of nuclei in myosin heavy chain positive 
cells containing at least two nuclei) in elderly subjects (83 ± 6 years old, n=3) when 
compared to young subjects (30 ± 2 years old, n=3); (Beccafico et al., 2007). They also 
have shown that myotubes derived from elderly subjects are thinner and contain few 
myonuclei compared to the ones derived from the young individual. 
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Beccafica et al. (2010) isolated myoblasts from the vastus lateralis muscle of 10 young 
(29 ± 6 years old) and 11 old (77 ± 6 years old) and cultured them in either growth 
media or differentiation media. These authors showed that myoblasts from older 
subjects displayed lower levels of Brdu incorporation when compared to younger 
subjects thus suggesting impaired proliferation in the elderly cells. Western blotting 
analysis revealed no expression of the early myogenic differentiation marker; 
myogenin; or the terminal differentiation marker, MHC in myoblasts derived from older 
subjects compared to younger subjects. In addition, when compared to those of younger 
subjects, the older myoblasts displayed significantly higher levels of S100B, an 
intracellular protein known to inhibit myoblast differentiation, and lower levels of 
membrane-bound RAGE, a receptor promoting myoblast differentiation. . Several other 
studies showed that human myoblasts extracted from muscles of elderly subjects do not 
fuse as efficiently in vitro as those from younger subjects (Jacquemin et al., 2004, 
Pietrangelo et al., 2009). There are a number of concerns which need to be borne in 
mind when drawing conclusions from some of these studies. For examples, some 
studies which have either identified age related impairments in human myoblast 
differentiation have compared only one individual from each age group (Jacquemin et 
al., 2004, Lorenzon et al., 2004). When populations from several young and several 
elderly donors have been compared this relationship is less clear and cells from several 
elderly subjects do show robust differentiation (Pietrangelo et al., 2009). Therefore any 
previous differences reported could be due to individual variability in factors (genetic or 
lifestyle factors) other than age. Further concerns centre on comparing populations that 
do not have equivalent proportions of cells expressing desmin (Beccafico et al., 2007, 
Pietrangelo et al., 2009), which have compared cells which have not been characterised 
in terms of desmin content (Beccafico et al., 2010).  
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In differentiation experiments it is particularly important to monitor the desmin content 
of the population carefully because this can vary over time in culture as demonstrated 
by data in Figures 3.2 and 3.4 and by Schafer et al. (2006). It is possible to increase the 
myogenic purity of a population by magnetic cell sorting with the cell surface marker 
NCAM (Pietrangelo et al., 2009, Schafer et al., 2006). Such purification result in an 
increase in fusion index for cells from a young subject but not from an elderly subject 
(Pietrangelo et al., 2009) and this was taken as demonstration of age related impairment. 
Morphological differences were also reported for myotubes formed from old and young 
myoblasts with the former being smaller and thinner (Pietrangelo et al., 2009). In the 
present study, a quantitative approach was undertaken to compare myotubes from 
young and elderly subjects. The result shows that there is no significant difference in 
myotube area between young and elderly myoblast. 
 
3.6.2 Non-senescent vs. senescent myoblasts 
Replicative senescence is characterised by an irreversible growth arrest with associated 
morphological and physiological alterations (Campisi and d'Adda di Fagagna, 2007). 
This phenomenon has been used as a model to study ageing in fibroblast and has been 
proposed as a model of ageing in myoblasts since myoblasts from an infant donor aged 
in vitro showed a delayed differentiation response, a lower fusion index and fewer 
nuclei per myotube compared to proliferating myoblasts from the same donor (Bigot et 
al., 2008). However, there is uncertainty as to how in vitro ageing of cells reflects the 
physiological ageing of similar cells in vivo. In the present experiment it was not 
possible to separate cells obtained from young and elderly people. In agreement with 
Bigot and co-workers (2008) senescent myoblasts exhibited a delay in myogenic 
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differentiation, a lower fusion index and a reduced in myotube area compared to early 
passage cells from both young and elderly donors. The results in the present study have 
not been able to show a difference in the senescent profile of young (20-23 years old) 
compared to elderly (67-82 years old) subjects. Undoubtedly in vivo ageing is 
associated with a reduction in various physiological function of muscle. It is unsure how 
the senescent in vitro relates to the findings found in vivo. It could be that if the cells 
from very old subjects were studied e.g. approaching 100 years old, then the 
characteristics of these cells pre in vitro senescence would more akin to those in the 
present study observed following multiple passaging to senescence in vitro may have 
not been observed. More experiments need to be done in order to definitively define the 
relationship between in vitro senescence and ageing in vivo.         
 
The observed reduced expression of MyoD in senescent myoblasts could be directly 
responsible for reduction differentiation potential as reflected by a decreased and a 
delay in myogenin and MHC expression. MyoD is a myogenic regulatory factor that 
required for myogenic commitment and differentiation (Berkes and Tapscott, 2005, 
Buckingham et al., 2003, Cooper et al., 1999). Furthermore, it has been shown that 
MyoD plays an integral role in regulating myogenin transcription and that myogenin 
subsequently cooperates with MyoD to activate expression of another set of genes (Cao 
et al., 2006). Both in vivo and in vitro studies have demonstrated that MyoD-deficient 
myoblasts show a reduced differentiation potential as determined by decreased ability to 
fuse and a reduction in the number of generated myotubes (Yablonka-Reuveni et al., 





Ageing and cellular senescence are characterised by increased DNA damage 
(Sedelnikova et al., 2004, Rube et al., 2011). The precise mechanism that may 
contribute to the cellular senescence has not been defined, the shortening of telomeres is 
thought to act as a mitotic clock that signals senescence when one or more telomeres 
reach a critical length (Mouly et al., 2005). In eukaryotes, telomere shortening occurs 
during ageing due to the inability of DNA polymerase to copy the ends of chromosomes 
with fidelity (Bodnar et al., 1998). The dysfunction of telomeres results in a DNA 
damage response characterized by the formation of double strand DNA breaks 
containing the phosphorylated histone H2AX (Celeste et al., 2002). To investigate 
whether DNA damage accumulates with both in vivo ageing and in vitro senescence in 
human myoblasts, γ-H2AX antibody staining was used to characterise DNA double 
strand breaks in the myoblasts from the donors of different ages, as well as in senescent 
myoblasts. Young and elderly myoblasts exhibited a similar expression of γ-H2AX, 
while senescent myoblasts displayed a much higher DNA damage. Senescence of 
human myoblasts accompanied by increased generation of reactive oxygen species, 
reduced mitochondrial mass and a decreased whole cell ATP level all of which can lead 
to increased damage of DNA (Minet and Gaster, 2012).  
 
Many studies on human fibroblasts have demonstrated an inverse relationship between 
donor age and replicative lifespan (Macieira-Coelho and Ponten, 1969, Schneider and 
Mitsui, 1976). This effect is inconsistent with a high number of healthy donor samples 
(Cristofalo et al., 1998). In human myoblasts, however, there appears to be no 
correlation between the age of the donor and the number of mean population doublings 
achieved before senescence (data presented Figure 3.3); (Decary et al., 1997, Mouly et 
al., 2005, Pietrangelo et al., 2009, Renault et al., 2000). Furthermore, it has also been 
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shown that myoblasts obtained from very elderly subjects (>80 years of age) behaved 
similarly to cell populations obtained from very young subjects (2-5 years of age) in 
terms of their mean population doublings (Schafer et al., 2006). One explanation that 
has been proposed is that satellite cells in healthy muscle would not normally undergo a 
significant number of divisions in vivo once growth has ceased and therefore would 
maintain their proliferative potential throughout the lifespan of the individual (Decary et 
al., 1997). A similar maintenance of differentiation capacity would also be coherent 
with this explanation. 
 
In conclusion, the data presented herein and in other studies in animals and humans 
suggest that skeletal muscle derived myoblasts obtained from old donors have both a 
robust proliferative and differentiation potential in vitro. It is possible that genetic and 
lifestyle heterogeneity between individuals is a larger contributor than age to observed 
variations of human myoblast behaviour in vitro and in vivo. The data suggest that serial 
passage and replicative senescence, but not in vivo ageing, result in a delay in myoblast 
differentiation and increase DNA damage. This questions the use of senescence in 
culture as a model of in vivo ageing. This study also demonstrates that careful 
monitoring of passage number and desmin content is critical for the comparison of 
myogenicity between different myoblast populations. The data would also indirectly 
support a role for environmental rather than cell intrinsic factors in impaired muscle 
















Chapter 4: Secretory profile of 
















In the previous chapter, a series of experiments were designed to characterise the 
intrinsic behaviour of cells from young, old and senescent myoblasts by using a cell 
culture approach and immunocytochemistry. The work described in this chapter 
examines the release of cytokine by human myotubes.  
4.1 Introduction 
Skeletal muscle is an endocrine active organ producing a variety of cytokines, the so-
called myokines, which are involved in regulation of muscle homeostasis (Pedersen and 
Febbraio, 2008). Skeletal muscle has recently been shown to be a major source of IL-6 
especially during exercise, where it plays a role in glucose and lipid metabolism in 
muscle (Ostrowski et al., 1998, Carey et al., 2006). In addition to IL-6, other potential 
myokines expressed and secreted by contracting skeletal muscle have been identified, 
including IL-8 and IL-15 (Chan et al., 2004, Nielsen et al., 2007). Recent studies have 
demonstrated that IL-4, IL-6, IL-7, IL-8, IL-13, TNF-α and TGF-β1 can be detected in 
medium conditioned by human myotubes differentiated from satellite cells (Haugen et 
al., 2010, Jacquemin et al., 2007, Lafreniere et al., 2006, Peterson and Pizza, 2009, 
Tsivitse et al., 2005). Furthermore, several factors have been detected in medium 
conditioned during differentiation of murine C2C12 skeletal muscle cells (Henningsen et 
al., 2010). A quantitative proteomics platform was used in the study to identify and 
quantitatively analyse 635 secreted proteins including 35 growth factors, 40 cytokines 
and 36 metallopeptidases. These results suggest that myokines could potentially be 






Ageing has been associated with systemic low-grade inflammation, the so-called 
inflammageing. Inflammageing is defined, in part, by increased serum and plasma 
levels of a variety of pro-inflammatory cytokines and growth factors, including IL-6, 
TNF-α, and TGF-β1 (Carlson et al., 2009a, Dobbs et al., 1999, Njemini et al., 2011, 
Paolisso et al., 1998, Wei et al., 1992). The impact of ageing on the cytokine secretion 
from human skeletal muscle cells remains uncharacterised.    
 
In the previous chapter data was shown which suggested that proliferative senescence is 
not a representative model for ageing of myoblasts as myoblasts from old people were 
not different from those of young subjects. However, there is evidence that senescent 
cells accumulate in vivo with increasing age and are found at sites of age related 
pathology (Dimri et al., 1995, Paradis et al., 2001, Vasile et al., 2001). Senescent cells 
secrete several cytokines which leads to altered cellular function and may also have an 
impact on overall tissue function. Senescent cells secrete high levels of IL-6, IL-8, IL-
1β and TGF-β all of which could be involved in the proliferative arrest and disrupted 
differentiation (chapter 3); (Coppe et al., 2010, Orjalo et al., 2009, Parrinello et al., 
2005, Tremain et al., 2000). 
 
Based on the data obtained in Chapter 3, it is predicted that no differences will be 
observed in the secretory profiles of young and old myoblasts at early passages, but that 
differences will be observed between early passage and senescent myoblasts. The 
cytokines chosen for examination include IL-4, IL-6, IL-7, IL-8, IL-13, TNF-α, and 
TGF-β1 which have been observed in differentiating myotubes and IL-6, IL-8, IL-1β 




Two time periods were chosen for analysis. The first 48 hours after placing cells in 
differentiation medium and the period between 72-120 hours. As shown in Chapter 3, 
Ki67 is still detectable in the first 24 hours, the same time that myogenin is first 
detected but no myotubes are observed. At day three, MHC expression starts. MHC 
expression coincides with myoblast fusion and myotube formation. Therefore the 
phenotype of cells changes dramatically between the two periods chosen for 
examination. An advantage of measuring cytokine production during differentiation is 
that the medium contains no serum.   
 
4.2 Aim 
There are two major aims of the this study  
1- To define the secretory profile of cells from young and old myoblasts during 
differentiation. 




The methods for myoblast extraction are detailed in the general methods chapter 
(Section 2.4.1), as are methods for expanding, storing, thawing and culturing (Section 
2.4). The methods for differentiation of young, old and senescent cells are detailed in 





4.3.1 Collecting condition medium 
At early passage (young and old cells) and late passage (senescent cells), aliquots of 
7000 cells were plated into a 96 well dishes in growth medium. After 24 hr, 
differentiation was induced by simply replacing growth medium with differentiation 
medium. Conditioned media (CM) were collected after two 48 hour incubation periods 
after placing the cells in DM: The period between day 0- and day 2 of differentiation 
(i.e. the first 48 hours in DM) and between days three and five of differentiation (i.e.72-
120 hours). CM was immediately stored at -70ºC.   
 
4.3.2 Luminex assay 
The Luminex assay was carried out as described in general methods chapter (section 
2.9). A panel of nine cytokines was investigated at different time points. In brief, an 
aliquot of culture supernatant was thawed prior to the experiments. 25-50 μl of each 
sample, the manufacturer provided positive control, negative control as well as standard 
curve samples were added to wells of the plate containing 25-50 μl of assay buffer and 
25-50 μl of diluted beads (1:2.5). The plate was sealed, covered with aluminium foil to 
protect it from light and incubated with agitation on a plate shaker overnight at 4ºC. The 
sample was then removed and washed 2X with washing buffer provided in the kit. 25-
50 μl of detection antibodies was added to each well and incubated for one hour at room 
temperature to bind the bead-cytokine complexes. Then Streptavidin-Phycoerythrin was 
added and incubated for thirty minutes at room temperature. The sample was then 
removed and washed 2X with washing buffer. One hundred microlitres of sheath fluid 
was then added to each well and the plate was read in a Luminex plate reader, where a 
red laser excited the fluorochromes in the beads and, the identity of the bead and 
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corresponding antigen were determined. At the same time a green laser excited the 
phycoerythrin coupled antibodies to determine the amount of cytokine associated with 
the specific bead. Samples were tested in duplicate and the average concentration for 
each sample was taken.  
 
4.4 Statistics  
Statistical comparisons were made using IBM SPSS 19 software, and P values ≤ 0.05 
were considered significant. Statistical significance for interactions between group 
(Young, Elderly and Senescent) and time was determined using mixed two-way 
repeated measure analysis of variance (ANOVA) with post-hoc Bonferroni. If there 
were significant interactions present, one way-ANOVA tests were conducted to confirm 
statistical significance between variable of interest, e.g. between groups, and paired-
sample t tests undertaken for variables of interest within group and time. Results for 
repeated measure and one-way ANOVA are expressed using the F-Ratio, whereas 




















An example of Luminex cytokine standard curve is presented in Figure 4.1. The data 
was plotted as Median Fluorescence Intensity (MFIs) vs. Calculated cytokine 
concentration (pg/ml) and R^2 = 0.99.  
IL-6 












Figure 4.1. A representative standard curve created for IL-6. 
A standard curve was created from the standards included, using 5PL-(parametric 








4.4.1 Cytokine secretion of differentiated human myotube 
The levels of TNF-α, IL-1β, IL-4, IL-7, IL-10 and IL13 were below the detection limits 
of the assay (0.13 pg/ml) in all young, elderly and senescent myoblasts.  
 
4.4.1.1 TGF-β1 
TGF-β1 was detected during the first 48 hours of incubation in DM for all groups 
observed. The concentration of TGF-β1 in the CM significantly declined in the second 
48 hour incubation period measured during differentiation, F (1, 11) = 141, P < 0.0005, 
(confirmed by a Paired t test, t13 = 6.3, P < 0.0005). There was also a significant 
interaction between groups and time, F (2, 11) = 19.3, P < 0.0005. There were no 
significant differences between young and elderly myoblasts in the level of expression 
of TGF-β1 at any of the time points examined (Figure 4.2a). Significant differences 
were found when senescent myoblasts were compared to young and elderly myoblasts 
at 0-48 hours, F (2, 11) = 43, P < 0.0005, and at 72-120 hours, F (2, 11) = 7.6, P = 0.008, 









4.4.1.2 IL-6  
IL-6 was detected in conditioned medium from some cells at the time intervals 
examined (Figure 4.3b). There was no time effect and no significant interaction between 
groups and time for IL-6 expression. There were no statistically significant differences 
in the amount of IL-6 detected among senescent, young and elderly myoblasts at any 
time periods examined (Figure 4.3a). Figure 4.3b shows the individual values for IL-6 
expression for each time point.  
 
4.4.1.3 IL-8 
The mean concentration of IL-8 significantly declined with time for all groups during 
myoblasts differentiation, F (1, 11) = 5.1, P = 0.045, (confirmed by a Paired t test, t13 = 
2.2, P = 0.043). There were no significant differences between young and elderly cells 
in the amount of IL-8 at any of the time periods examined (Figure 4.4a). The level of 
IL-8 at 0-48 hours had a trend to be higher in senescent myoblasts compared to young 
and elderly myoblasts, F (2, 11) = 4, P = 0.05. The difference between senescent and early 
passage myoblasts was however statistically significant at 72-120 hours, F (2, 11) = 5.5, P 
= 0.022, (Figure 4.4a). Figure 4.4b shows the individual values for IL-8 expression for 
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Figure 4.2. (a) TGF-β1 levels for young, old and senescent myoblasts during 
differentiation. Medium was conditioned for 48 hours for two different periods of 
differentiation. The concentration was measured in media from muscle cells obtained 
from young (n=5) and elderly (n=4) subjects. Cells were either differentiated at early 
passage (in vivo ageing model) or when they reached replicative senescence (n=5). Data 
are mean value ± SE. *, P <0.0005 & **, P = 0.008 statistically significant difference 
from young and elderly subjects. (b) Individual data points are shown for TGF-beta 
expression during myoblast differentiation. Individual points are represented by the 
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Figure 4.3. (a) IL-6 levels for young, old and senescent myoblasts during 
differentiation. Medium was conditioned for 48 hours for two different periods of 
differentiation. The concentration was measured in media from muscle cells obtained 
from young (n=5) and elderly (n=4) subjects. Cells were either differentiated at early 
passage (in vivo ageing model) or when they reached replicative senescence (n=5). Data 
are mean value ± SE. (b) Individual data points for are shown for IL-6 expression 
during myoblast differentiation. Individual points are represented by the following 
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Figure 4.4. (a) IL-8 levels for young, old and senescent myoblasts during 
differentiation. Medium was conditioned for 48 hours for two different periods of 
differentiation. The concentration was measured in media from muscle cells obtained 
from young (n=5) and elderly (n=4) subjects. Cells were either differentiated at early 
passage (in vivo ageing model) or when they reached replicative senescence (n=5). Data 
are mean value ± SE. *, p = 0.022 statistically significant difference from young and 
elderly subjects. (b) Individual data points are shown for IL-6 expression during 
myoblast differentiation. Individual points are represented by the following symbols: 




This is the first study on the effect of ageing and senescence on the cytokine secretion 
during human myoblast differentiation. This study revealed two main findings. Firstly, 
there was no significant difference between young and old myoblasts in the level of 
expression of detectable cytokines at any of the time periods examined. Secondly, when 
the cells reached senescence, secretion of TGF-β1 and IL-8 was increased compared to 
early passage myoblasts. 
 
It is now widely accepted that skeletal muscle cells cultures express several cytokines 
which are involved in maintaining a balance between growth and differentiation of 
satellite cells (Charge and Rudnicki, 2004). Detection of IL-4, IL-6, IL-7, IL-8, IL-13, 
TNF-α and TGF-β1 has been reported in condition medium during differentiation of 
human skeletal muscle primary cultures (Haugen et al., 2010, Jacquemin et al., 2007, 
Lafreniere et al., 2006, Nagaraju et al., 1998, Peterson and Pizza, 2009, Tsivitse et al., 
2005), but none of these studies used subjects older than 35 years of age. Nine different 
cytokines were tested in the media from young, old and senescent myotubes using a 
Luminex based assay. IL-6, IL-8 and TGF-β1 were detectable above baseline. In the 
present study, TGF-β1, IL-6 and IL-8 are predominantly secreted during the first 48 
hours in differentiation medium as the concentration of TGF-β1 and IL-8 decreased 
dramatically with time. This suggests that myoblasts and not myotubes produce the 
most TGF-β1 and IL-8, and may indicate that production of these molecules is highest 
in cells in GM rather than DM. The level of cytokines is GM was not measured. 
Additionally, there was no age related difference in TGF-β1, IL-6 and IL-8 expression 
in myoblast differentiation. The data reported herein are in agreement with earlier 
observations showing that no age related difference in TNF-α, IL-6, IL-1β and TGF-β 
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mRNA expression in human skeletal muscle (Hamada et al., 2005, Pedersen et al., 
2004). Taken together the data indicate that these TGF-β1, IL-6 and IL-8 should be 
classified as a myokines and may exert their effect in an autocrine or paracrine fashion. 
 
On the other hand, some of the cytokines previously thought to be skeletal muscle 
derived (IL-4, IL-7, IL-13 and TNF-α) and produced during differentiation were below 
the detection range in our culture. This could be explained in several ways. First, 
methods for cell extraction and digestion and, assays for detection of cytokines and, in 
the composition of differentiation medium differed between the present and previous 
studies. Secondly, some studies (Jacquemin et al., 2007, Lafreniere et al., 2006, 
Peterson and Pizza, 2009, Tsivitse et al., 2005) examined myoblasts derived from only 
one donor individual. Although not examined in this or any of the studies cited herein, it 
is possible that production of the complete cytokine profile detected in muscle in vivo 
depends on interactions with certain cell types such as fibroblasts and neurones. Finally, 
skeletal muscle cells might not produce these mediators during differentiation in vitro 
cell cultures.    
 
Interestingly senescent cells showed differences in TGF-β and IL8, but not IL6, when 
compared to early passage cells. It has been shown that persistence of DNA damage 
induces senescent growth arrest and, IL-6 and IL-8 secretion (Rodier et al., 2009, 
Rodier et al., 2011). Experiments in the previous chapter showed that senescent 
myoblast populations displays a markedly high proportion of DNA damaged compared 
to early passage myoblasts, so it could be suggested that senescence-associated 
inflammatory cytokine secretion is a consequence of DNA damage occurring during in 
vitro passage and not in vivo ageing.  
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TGF-β is an important cytokine that is involved in regulating skeletal muscle myogensis 
(Zentella and Massague, 1992, Carlson et al., 2009a). In tissue culture experiments, it 
has been shown that TGF-β1 is secreted during myoblast proliferation and 
differentiation (Henningsen et al., 2010, Lafyatis et al., 1991, Nagaraju et al., 1998). 
Other studies have also demonstrated that fusing satellite cells and newly formed 
myotubes contain strong TGF-β immunoreactivity during skeletal muscle regeneration, 
providing evidence for TGF-β role in myoblast fusion (McLennan and Koishi, 1997). In 
contrast to these findings, TGF-β1 is also capable of inhibiting satellite cell proliferation 
and differentiation (Allen and Boxhorn, 1987, Carlson et al., 2009b). The present study 
shows that senescent cells secrete high concentrations of TGF-β1 (250-300 pg/ml) in 
the first 48 hours of differentiation. Senescent cells neither express myogenin, MHC nor 
fuse. Thus it could be suggested that TGF-β1 production and inability of senescent cells 
to differentiate are related and this examined in Chapter 5. 
 
IL-8 belongs to a large family of chemokines that attract primarily neutrophils and act 
as angiogenic factors (Pedersen and Febbraio, 2008). The role of IL-8 within the muscle 
is still not fully characterised. IL-8 mRNA has been shown to be enhanced during 
exercise and IL-8 protein expression within skeletal muscle fibres in the recovery from 
exercise (Akerstrom et al., 2005, Chan et al., 2004). Recent evidence demonstrated that 
IL-8 protein is also detected in media during differentiation of human skeletal muscle 
derived myoblasts (Peterson and Pizza, 2009, Tsivitse et al., 2005), but no direct effect 
on muscle cells has been reported. The effect of IL-8 on proliferation and differentiation 





IL-6 is a pleiotropic cytokine that is secreted and produced by skeletal muscle cells 
under various conditions where it plays an important role in insulin sensitivity and 
lipolysis (Carey et al., 2006, Weigert et al., 2005, Wolsk et al., 2010). Exercise rapidly 
increases the nuclear transcriptional rate of IL-6 within the contracting muscles, with a 
10- to 20-fold increase in mRNA content observed following 30 minutes of “non-
damaging” exercise and a possible peak (up to 100-fold) immediately at the end of the 
exercise bout (Keller et al., 2001). Furthermore, the cytokine IL-6 is produced and 
released by muscle fibres into the circulation during exercise (Penkowa et al., 2003). 
The muscle-derived IL-6 therefore appears to act in an endocrine manner and may help 
to explain some of the beneficial effects associated with exercise. 
 
There is evidence that, in addition to its endocrine effects, IL-6 may be involved in 
regulating processes occurring locally within the muscle producing it. Exogenous IL-6 
has been shown to promote myoblast proliferation and differentiation (Baeza-Raja and 
Munoz-Canoves, 2004, Okazaki et al., 1996, Wang et al., 2008). IL-6 expression is 
induced during differentiation of C2C12 myoblasts and this is controlled by the p38/NF-
кB pathway (Baeza-Raja and Munoz-Canoves, 2004). Moreover, the ablation of IL-6 in 
myoblasts decreases the expression of differentiation-associated genes such as 
myogenin. Conversely, overexpression of IL-6 increases the extent of myogenic 
differentiation (Baeza-Raja and Munoz-Canoves, 2004). IL-6 is also necessary for 
myofibre growth under certain conditions. In young mice, growing myofibres as well as 
associated satellite cells actively produce IL-6 (Serrano et al., 2008). When IL-6 
expression is eliminated genetically in these mice, hypertrophy is adversely affected in 
vivo. Taken together, these results suggest that this cytokine may be involved in both 
satellite cell proliferation and fusion, as well as playing a role in muscle hypertrophy. It 
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might thus have been expected that IL-6 production would decrease in senescent cells 
but this was not observed. This shows that maintenance of IL-6 expression is not 
sufficient to sustain differentiation in senescent cells. Alternatively the myogenic 
inhibitory effects of TGF-β1, discussed above, could be dominant as the concentration 
of this cytokine was significantly higher at time periods measured.  
 
To conclude, myotubes have been used as an in vitro model of skeletal muscle for many 
years, and are therefore well suited for finding, identifying and studying new muscle 
derived cytokines (myokines) in vitro. Investigation of the secretory profile of human 
myoblast during differentiation provides clear evidence that there are several muscle-
derived myokines that have direct effects on muscle cells. This strongly suggests that 
these molecules can act locally and may exert their effect in an autocrine or paracrine 
manner in vivo. No significant difference was observed between young and elderly 
myoblasts in the level of expression of TGF-β1, IL-6 and IL-8 at any of the time 
intervals measured. This study revealed that only senescent myoblasts display a 
markedly higher TGF-β1 and slightly higher IL-8 secretion compared to early passage 
myoblasts. Further studies are required to explore the role of cytokines on the behaviour 
of human myoblasts (Chapter 5).  
 
   
 















Chapter 5: Effects of inflammatory 

















Several cytokines have been proposed to affect the behaviour of satellite cells within the 
aged environment. These include TGF-β1, TNF-α, IL-1β and IL-6. In addition, 
senescent myoblasts secreted high levels of TGF-β1 and IL-8 compared to early passage 
myoblasts from both young and elderly people (chapter 4). The work described in this 
chapter examines the effects of these cytokines on the behaviour of human myoblasts. 
5.1 Introduction    
In normal adult muscle tissue satellite cells exist in a quiescent state, but upon muscle 
injury these cells becomes activated and proliferate to give rise to a population of 
myogenic precursors which are capable of repairing or replacing the damaged muscle 
(Bischoff, 1975, Konigsberg et al., 1975, Morgan and Partridge, 2003, Moss and 
Leblond, 1971, Snow, 1977b). Soluble endocrine, paracrine and autocrine factors have 
been identified which play a crucial role in muscle regeneration by either stimulating or 
inhibiting proliferation and differentiation of myoblasts (Table 5.1). These include 
TGF-β, TNF-α, IL-1β and IL-6. It has been shown that plasma/serum (circulating) and 
local tissue cytokine levels become elevated with age (Table 5.2) and this has been 
suggested as a mechanism by which satellite cell activation is impaired in older muscle.  
 
Previous studies performed concerning TGF-β, TNF-α, IL-1β and IL-6 and their effect 
on satellite cell behaviour are contradictory (Table 5.1). The majority of studies only 
focus on one specific concentration of these cytokines which is higher than the 
physiological range. Therefore, the major aim of this study was to provide a more 
comprehensive assessment of the effects of these physiologically relevant doses of these 




5.2 Aim    
The effects of the cytokines were examined at different time points in the culture 
procedure: 1) immediately following enzymatic digestion and isolation when the 
majority of cells have not started to express desmin and are termed freshly isolated 
cells; 2) after expansion for one to two weeks of culture when the cells are expressing 
desmin and termed committed. All of the committed myoblasts used here are from same 
populations used in Chapters 3 and 4.  
 
 
Table 5.1. Studies on the effect of cytokines on the proliferation and differentiation of 
myoblasts. 
 
Cytokine Model Dosage Finding Reference 
TGF-β Human 25 ng/ml Inhibit proliferation and 
differentiation 
(Carlson et al., 
2009b) 
C2C12 5 ng/ml Promote proliferation and 
inhibit differentiation 
(Schabort et al., 
2009) 




Human 10 ng/ml Promote proliferation and 
no effects on 
differentiation 
(Wang et al., 
2008) 
C2C12 2 ng/ml Induce differentiation (Baeza-Raja and 
Munoz-
Canoves, 2004) 
TNF-α C2C12 10 ng/ml Promote proliferation and 
inhibit differentiation 
(Langen et al., 
2004)  




C2C12 0.05 ng/m Stimulate differentiation 
 
(Chen et al., 
2007) 
0.5-5 ng/ml Inhibit differentiation 















Young  Elderly Reference 
TGF-β 
 




0.89 pg/ml 2.09 pg/ml (Ferrucci et al., 
2005, Njemini et 
al., 2011) 





Prior to acceptance in the study, participants completed a health questionnaire and were 
only included if they fulfilled the “healthy” or “medically stable” criteria (Greig et al., 
1994). Muscle biopsies were collected from 8 young (aged 23-27 years) individuals. 
 
5.3.2 Treatment of myoblasts with cytokines 
5.3.2.1 Treatment of freshly isolated cells with cytokines  
The methods for myoblast extraction are detailed in the general methods chapter 
(Section 2.4.1), as are methods for expanding, storing, thawing and culture after 
thawing in growth medium (Section 2.4and 2.6). The methods for treatment of freshly 
isolated myoblasts with cytokines are detailed in Section 2.5.2 and described briefly 
below. Cell pellets obtained after enzymatic digestion were resuspended in serum free 
medium, counted and plated in 24 well plates containing culture medium with double 
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concentrations of FCS, PSG and cytokines relative to the desired final concentration.  
For differentiation experiments, cells were initially plated in growth medium for three 
days and then transferred to differentiation medium with 0.5% BSA with or without 
(control) cytokines as specified in the figures. DM was changed every 48 hours and the 
cells fixed for immunocytochemical analysis on the seventh day of differentiation.  
 
5.3.2.2 Treatment of committed myoblasts with cytokines 
Cells were thawed, passaged once (Chapter 2, Section 2.4), and cultured in skeletal 
muscle cell growth medium to 50% confluence. At this point, cells were plated in 96 
well dishes at a density of 1000 cells/well in the presence or absence of human 
recombinant TGF-β1, TNF-α, IL-1β, IL-6 or IL-8 at concentrations ranging between 1 
pg/ml and 10 ng/ml. Cells were fixed after 3 days and different antigens were examined 
by immunocytochemistry (Chapter 2, Section 2.8). For differentiation assays, cells were 
cultured in a skeletal muscle cell growth medium to 50% confluence and plated in 96 
well dishes at a density of 7000 cells/well. Media were replaced after 24 hr with 
differentiation medium containing 0.5% BSA and 1% PS (100 units/ml Penicillin, 100 
μg/ml Streptomycin) in the presence or absence of human recombinant TGF-β1, TNF-α, 
IL-1β, IL-6 or IL-8 at concentrations ranging from 1 pg/ml to 1 ng/ml as specified in the 
text and figures. Cells were fixed after 3 days and myogenin expression was examined 






5.4 Statistics  
Statistical comparisons were made using IBM SPSS 19 software, and P values ≤ 0.05 
were considered significant. One-way analysis of variance (ANOVA) with post-hoc 
Dunnett comparisons to control was conducted to confirm statistical significance 
between variables of interest, e.g. between treated and non-treated cells. Statistical 
significance for interactions between groups (Control, 100 pg/ml TGF-β1 and 300 
pg/ml TGF-β1) and time was determined using mixed two-way repeated measure 
ANOVA with post-hoc Bonferroni. Results for repeated measure and one-way ANOVA 
are expressed using the F-Ratio. All values are expressed as mean ± SE.    
 
5.5 Results 
5.5.1 Effects of cytokines on proliferation and myogenic commitment 
of freshly isolated myoblasts 
5.5.1.1 TGF-β1 and TNF-α  
Typical staining patterns of desmin and Ki67 are shown in Figure 5.1. Freshly isolated 
human myoblasts were cultured in the presence or absence of human recombinant TGF-
β1 (1 pg/ml, 100 pg/ml, 1 ng/ml, 2 ng/ml and 25 ng/ml) or human recombinant TNF-α 
(1 pg/ml, 100 pg/ml, 1 ng/ml, 10 ng/ml and 50 ng/ml) and monitored for three days 
(Figure 5.2a-b). The number of cells expressing desmin at this time was significantly 
lower in the treated cultures and this appeared to be a dose dependent response to both 
TGF-β1, F (5, 24) = 24, P < 0.0005, and TNF-α, F (5, 18) = 30, P < 0.0005. Only 
concentrations above 1ng/ml were effective as no statistically significant differences 
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were observed in the percentage of desmin expressing cells between control and treated 
cells at concentrations of 1-100 pg/ml. No significant differences were observed in the 
percentage of Ki67 expressing cells between treated and untreated myoblasts. 
 
5.5.1.2 IL-1β, IL-6 and IL-8 
There were not sufficient values to carry out statistical analysis. Data are presented as 
mean percentage of the two experiments for IL-1β and as percentage for one experiment 
for IL-6 and IL-8 (mean of two wells). 
 
Freshly isolated human myoblasts were cultured in the presence or absence of human 
recombinant IL-1β, IL-6 or IL-8 (1 pg/ml, 100 pg/ml, 1 ng/ml and 10 ng/ml) and 
monitored for three days (Figure 5.3a-c). It was observed that the number of desmin 
expressing cells was lower for IL-1β treated cells than control and the response 
appeared to be dose-dependent with effects only observed at concentrations above 
1ng/ml. The percentage of Ki67 expressing cells was similar between control and IL-1β 






































Figure 5.1. Images taken from of freshly isolated myoblasts in the absence (a) or (b) 
presence of TGF-β1, (c) TNF-α, (d) IL-1β, (e) IL-6, or (f) IL-8 at 1 ng/ml stained for 
desmin (green), Ki67 (red) and Hoechst 33342 (blue) . Scale bar = 20 µm. The number 
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Figure 5.2. Effects of TGF-β1 and TNF-α on the proliferation and commitment of 
freshly isolated myoblasts. Freshly isolated human myoblasts were cultured in the 
presence or absence (a) of human recombinant TGF-β1 (n=5) (1 pg/ml, 100 pg/ml, 1 
ng/ml, 2 ng/ml and 25 ng/ml) or (b) human recombinant TNF-α (n=4) (1 pg/ml, 100 
pg/ml, 1 ng/ml, 10 ng/ml and 50 ng/ml)   and monitored for three days. Data are mean 



























































































































































Figure 5.3. Effects of IL-1β, IL-6 and IL-8 on the proliferation and commitment of 
freshly isolated myoblasts. Freshly isolated human myoblasts were cultured in the 
presence or absence (a) of IL-1β (n=2), (b) IL-6 (n=1) or (c) IL-8 (n=1) (1 pg/ml, 100 
pg/ml, 1 ng/ml and 10 ng/ml) and monitored for three days.  
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5.5.1.3 Reversibility of the effects of treatment with inflammatory 
cytokines 
To investigate whether the effect of TGF-β1, TNF-α or IL-1β on desmin expression was 
reversible, freshly isolated human myoblasts were cultured in the presence or absence of 
the cytokines at 1ng/ml. After three days, the medium was removed and the cells were 
culture for an additional two days in growth medium. The data presented in Figure 5.4 
shows that desmin expression was completely restored 2 days after removal of TGF-β1, 
TNF-α or IL-1β.   
 
5.5.2 Effects of cytokines on NCAM expression in freshly isolated 
myoblasts  
Representative images of NCAM are shown in Figure 5.5. Freshly isolated human 
myoblasts were cultured in the presence or absence of 1ng/ml human recombinant TGF-
β1, human recombinant TNF-α, or human recombinant IL-1β and examined after three 
days (Figure 5.6). The number of cells expressing NCAM was similar under all 
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Figure 5.4. Reversibility effects on desmin expression after removal of inflammatory 
cytokines. Freshly isolated human myoblasts were cultured in the presence or absence 
(a) of human recombinant TGF-β1 (n=3), human recombinant TNF-α (n=3) or (b) 
human recombinant IL-1β (n=2). After three days, TGF-β1, TNF-α or IL-1β was 
removed and the cells were culture for an additional 2 days in growth medium. Data are 
mean value ± SE. * P < 0.0005 statistically significant difference from control and after 















Figure 5.5. Images taken from of freshly isolated myoblasts in the absence (a) or (b) 
presence of TGF-β1, or (c) TNF-α at 1 ng/ml stained for NCAM (green) and Hoechst 
33342 (blue). Scale bar = 20 µm. The number of cells expressing NCAM was similar 















































Figure 5.6. Inflammatory cytokines did not affect NCAM expression. 
Freshly isolated human myoblasts were cultured in the presence or absence of human 
recombinant TGF-β1 (n=3), or human recombinant TNF-α (n=3), or human 
recombinant IL-1β (n=3) (1 ng/ml) and examined after three days. No significant 
differences were observed in the presence and absence of the cytokines. Data are mean 










5.5.3 Differentiation of freshly isolated myoblasts 
Representative images of myogenin are shown in Figure 5.7. The number of cells 
expressing myogenin was significantly lower following treatment with both TGF-β1 
and TNF-α, F (2, 6) = 63, P < 0.0005, (Figure 5.8). The same inhibition of myogenin 
expression was observed following treatment with IL-1β (figure 5.8) but there were not 
























Figure 5.7. Images taken from of freshly isolated myoblasts in the absence (a) or (b) 
presence of TGF-β1 at 1 ng/ml stained for myogenin (yellow arrow) and Hoechst 33342 
(white arrow). Scale bar = 20 µm. The number of cells expressing myogenin was 




























































Figure 5.8. % of cells labelled for myogenin following treatment with TGF-β1, TNF-α 
or IL-1β. Freshly isolated human myoblasts were first cultured in growth medium for 
three days and subsequently transferred to differentiation medium in the presence or 
absence of 1 ng/ml human recombinant TGF-β1 (n=3), human recombinant TNF-α 
(n=3) or human recombinant IL-1β (n=2) and monitored for seven days. Data are mean 

















5.5.4 Proliferation and commitment of committed myoblasts 
In contrast to freshly isolated myoblasts, the committed myoblasts showed no difference 
in desmin expression following three days of treatment with TGF-β1, TNF-α, or IL-1β 
at concentration of 1 pg/ml and 10 ng/ml (Figure 5.10a-b). IL-6 and IL-8 also had no 
effect on desmin expression as was observed with the freshly isolated myoblasts. The 
expression of Ki67 was similar between committed myoblasts in the presence or 
absence of all the cytokines tested (Figure 5.10a-b). Typical staining patterns of desmin 













Figure 5.9. Images taken from of established myoblasts in the absence (a) or (b) 
presence of TGF-β1 at 10 ng/ml stained for desmin (green), Ki67 (red) and Hoechst 
33342 (blue). Scale bar = 20 µm. The number of desmin and Ki67 expressing cells was 





































































































Figure 5.10. Profile of desmin and Ki67 expression in committed myoblasts cultured in 
the presence or absence of inflammatory cytokines. Myoblasts from young (n=3) 
subjects were cultured in growth medium for 3 days in the presence or absence (a) of  
TGF-β1, TNF-α, IL-1β or (b) IL-6 or IL-8 and stained for desmin and Ki67. No 
significant differences were observed between treated and untreated myoblasts (P ≤ 




5.5.5 Differentiation of committed myoblasts 
Representative images of myogenin are shown in Figure 5.11. Committed human 
myoblasts were first cultured in growth medium for 24 hours and subsequently 
transferred to differentiation medium in the presence or absence of human recombinant 
TGF-β1, TNF-α or IL-1β at 1 pg/ml, 100 pg/ml and 1 ng/ml and monitored for three 
days (Figure 5.12a-c). The number of cells expressing myogenin was significantly 
lowered when cells were treated with 1 ng/ml of TGF-β1, F (3, 8) = 113, P < 0.0005, 
TNF-α, F (3, 8) = 27, P < 0.0005, or IL-1β, F (3, 8) = 49, P < 0.0005, when compared to 
control cells. TNF-a and IL-1β were also effective at inhibiting myogenin expression at 
concentrations of 100pg/ml but not at 1 pg/ml. IL-6 and IL-8 had no effect on myogenin 

































Figure 5.11. Images taken from of established myoblasts in the absence (a) or (b) 
presence of TGF-β1, (c) TNF-α, (d) IL-1β, (e) IL-6, or (f) IL-8 at 1 ng/ml stained for 
myogenin (yellow arrow) and Hoechst 33342 (white arrow) . Scale bar = 20 µm. The 
number of myogenin expressing cells was lower for TGF-β1, TNF-α and IL-1β treated 
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Figure 5.12. % of cells labelled for myogenin following treatment with (a) TGF-β1, (b) 
TNF-α, (c) IL-1β. Committed human myoblasts (n=3) were first cultured in growth 
medium for 24 hours and subsequently transferred to differentiation medium in the 
presence or absence of human recombinant TGF-β1 or TNF-α or IL-1β  at 1 pg/ml, 100 
pg/ml and 1 ng/ml and monitored for three days. Data are mean value ± SE. *, P < 
0.0005, **, P = 0.003 & 
#
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Figure 5.13. % of cells labelled for myogenin in the presence or absence (a) IL-6 (b) 
IL-8. Committed human myoblasts (n=3) were first cultured in growth medium for 24 
hours and subsequently transferred to differentiation medium in the presence or absence 
of human recombinant IL-6 or IL-8 at 1 pg/ml, 100 pg/ml and 1 ng/ml and monitored 
for three days. No significant differences were observed between treated and non-




5.5.6 Time course inhibition of myogenin in the presence of 300 pg/ml 
TGF-β1 
Experiments in the previous chapter showed that senescent myoblasts secreted high 
concentrations of TGF-β1 (250-300 pg/ml) compared to both cells from young and 
elderly subjects (100-150 pg/ml). In order to examined whether these concentrations are 
inhibitory, committed human myoblasts were cultured in growth medium for 24 hours 
and subsequently transferred to differentiation medium in the presence or absence of 
human recombinant TGF-β1 at 100 pg/ml or 300 pg/ml. Cells were cultured for a 
further 7 days in differentiation medium, with aliquots of cells being fixed every 24 hr. 
In parallel, after 3 days, 300 pg/ml TGF-β1 was removed and the cells were culture for 
an additional 4 days in the presence of TGF-β1 at 100 pg/ml (Figure 5.15). There was a 
significant interaction between groups and time, F (2, 6) = 208, P < 0.0005, during 
myoblasts differentiation. The number of cells expressing myogenin was decreased in 
the presence of TGF-β1 at 300 pg/ml when compared to cells treated with 100 pg/ml 
and control cells. The data presented in Figure 5.15 shows that myogenin expression 
was completely restored 24 hours after reduction of TGF-β1 from 300 pg/ml to 100 
pg/ml. Representative images of myogenin are shown in Figure 5.14.    
   
     










Figure 5.14. Images taken from of established myoblasts in the absence (a) or (b) 
presence of TGF-β1 at 300 pg/ml stained for myogenin (green) and Hoechst 33342 
(blue) after 7 days in differentiation medium. Scale bar = 20 µm. The number of cells 
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Figure 5.15. Time course of myogenin expression in the presence or absence of TGF-
β1. Committed human myoblasts (n=3) were first cultured in growth medium for 24 
hours and subsequently transferred to differentiation medium in the presence or absence 
of human recombinant TGF-β1 at 100 pg/ml or 300 pg/ml. Cells were cultured for a 
further 7 days in differentiation medium, with aliquots of cells being fixed every 24 hr. 
In some wells 300 pg/ml TGF-β1 was substituted with 100 pg/ml after three days and 
the cells were cultured for an additional 4 days in under this condition. Data are mean 
value ± SE. *, P < 0.0005 statistically significant difference from control.
 
 
   







5.5 Discussion  
This is the first study on the effect of inflammatory cytokines on the behaviour of 
freshly isolated myoblasts at very early stages following enzymatic dissociation of 
muscle from biopsy tissue. It is also the first to test the effect of physiologically relevant 
doses of TGF-β1, TNF-α, IL-1β, IL-6 and IL-8 on committed myoblasts. This study 
revealed several findings. Firstly, none of the cytokines tested had any effect on the 
expression of the proliferation marker Ki67 on any of the cells tested. Secondly, desmin 
and myogenin expression were significantly inhibited in freshly isolated myoblasts 
exposed to TGF-β1, TNF-α, or IL-1β, and this effect was reversible. Thirdly, myogenin 
but not desmin expression was significantly inhibited in committed myoblasts in the 
presence of TGF-β1, TNF-α, or IL-1β. Taken together the data suggest the cytokines 
have no effect on proliferation of myoblasts but do inhibit progression of both myogenic 
commitment and differentiation in these cells. Furthermore, the cytokines inhibit 
myogenic progression but are unable to reverse it. The latter point is supported by two 
observations: 1) the cytokines do not inhibit NCAM expression in freshly isolated cells 
since satellite cells express this marker in the quiescent state in vivo; 2) the cytokines do 
not inhibit desmin expression in committed myoblasts, at least in populations that show 
stable expression of this protein.  
 
The reported findings regarding the effects of TGF-β1 and TNF-α on myoblast 
proliferation are contradictory. Some studies suggesting these cytokines promote 
(Langen et al., 2001, Langen et al., 2004, Schabort et al., 2009) and others that they 
inhibit (Carlson et al., 2009b, Layne and Farmer, 1999) proliferation of myoblasts. The 
discrepancies may be attributed to differences in the doses used. In the present study, it 
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was shown that TGF-β1 or TNF-α do not affect myoblast proliferation in a dose 
dependent manner in both freshly isolated and committed myoblasts.  
 
The available data does show that differentiation of human myoblasts in culture is 
negatively affected by TGF-β1 and TNF-α in a dose dependent manner. It has been 
shown that either TGF-β1 or TNF-α inhibit the transcriptional activity of MyoD and 
myogenin (Langen et al., 2001, Liu et al., 2001, Martin et al., 1992, Rathbone et al., 
2011, Sharples et al., 2010), suggesting a mechanism by which TGF-β1 or TNF-α could 
regulate differentiation of myoblasts. MyoD is a myogenic regulatory factor required for 
myogenic commitment and differentiation (Berkes and Tapscott, 2005, Buckingham et 
al., 2003, Cooper et al., 1999). Furthermore, it has been shown that MyoD plays an 
integral role in myogenin activation and myogenin subsequently cooperates with MyoD 
to activate expression of other sets of genes (Cao et al., 2006). Both in vivo and in vitro 
studies have demonstrated that MyoD-deficient myoblasts show a reduced ability to 
fuse, a reduction in the number of generated myotubes, and consequently a reduced 
differentiation potential (Yablonka-Reuveni et al., 1999, Megeney et al., 1996, 
Montarras et al., 2000, Sabourin et al., 1999). Although MyoD expression was not 
analysed in the experiments presented herein, the above provides an explanation for the 
inhibition of myogenin expression during differentiation of both freshly isolated and 







TGF-β1 and TNF-α have also been shown to induce expression of cyclin D1, which is 
involved in progression from the G1 to S phases of the cell cycle and to negatively 
affect cell cycle exit thereby leading to inhibition of myoblast differentiation (Langen et 
al., 2004, Rao and Kohtz, 1995). Both the absence of an effect of TGF-β1 and TNF-α 
on Ki67 expression as well as their inhibitory effects on myogenin expression could 
potentially be explained by this mechanism. Continued Ki67 expression in serum free 
DM in the presence of the cytokines was not investigated, however, and it is thus not 
possible to assert conclusively whether inhibition of cell cycle arrest was a contributory 
factor to the lack of myogenic progression observed.  
 
IL-1β is a pleiotropic pro-inflammatory cytokine, which has been considered a 
pathological factor in different conditions such as inflammatory myopathies and 
diabetes (Authier et al., 1997, Lundberg et al., 2000, Maedler et al., 2002). The 
physiological concentration of IL-1β in serum at rest has been reported to be 2.04 ± 4.93 
pg/ml in young and 2.52 ± 7.41 in elderly subjects (Kim et al., 2011a). IL-1β is 
produced by skeletal muscle where it plays an important role in muscle protein 
breakdown by activating p38 MAPK and NFкB, and the muscle specific ubiquitin 
ligases atrogin-1/MAFbx and MuRF-1 (Authier et al., 1997, Jozsi et al., 2000, Li et al., 
2009). To the author knowledge only one group has investigated the effect of IL-1β on 
the differentiation of myoblasts into myotubes (Langen et al., 2001). Culturing C2C12 
myoblasts in the presence of 0.1-10 ng/ml IL-1β has been shown to inhibit 
differentiation. In agreement with this observation, the present study shows that IL-1β 
inhibits desmin expression, sustains proliferation and inhibits differentiation of freshly 
isolated human myoblasts at doses of 100 pg/ml but not at 1pg/ml, closer to the reported 
serum concentrations. The inhibition of desmin expression in freshly isolated myoblasts 
 157 
 
was reversible after removal of IL-1β from the medium. It is possible that IL-1β acts 
through similar mechanisms to TGF-β1 and TNF-α by either inhibiting MyoD 
expression or inducing cyclin expression and action, but this possibility has not been 
tested.  
 
It has been proposed that TGF-β1 induces trans-differentiation of myoblasts into 
fibroblasts (Cencetti et al., 2010). In order to examine whether TGF-β1, TNF-α, or IL-
1β affected the phenotype of myoblasts, freshly isolated human cells were cultured in 
the presence or absence of the cytokines and stained for NCAM after three days of 
culture. NCAM is a marker of satellite cells used for their identification in histological 
sections of resting muscle (Mackey et al., 2010, Mackey et al., 2009) as well as for 
magnetic sorting of myoblasts cultures (Pietrangelo et al., 2009). The results showing 
that NCAM expression was similar between treated and untreated myoblasts, indicates 
that none of the cytokines tested induced trans-differentiation myoblasts into a different 
cell type. Rather, it appears that by reversibly inhibiting expression of the muscle 
regulatory factors without affecting proliferation, these cytokines can maintain the cells 
in an immature state. The length of time over which treatment with these cytokines can 
maintain this immature state and still be fully reversible, without affecting the 
proliferation or differentiation potential, of the myoblasts remains to be determined.  
 
The three cytokines may act through similar signalling mechanisms to exert their effect. 
E-box and MEF2 binding sites are indispensable for desmin and myogenin expression 
(Du et al., 2003, Li and Capetanaki, 1994). It has been shown that TGF-β through 
Smad3 inhibits E-box and MEF2 dependent transcription which subsequently lead to 
inhibition of myoblasts differentiation (Liu et al., 2001, Liu et al., 2004). More recently, 
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TNF-α and IL-1α have been shown to induce secretion of Activin A which subsequently 
inhibits human myoblast differentiation via ALK/SMAD2/3 signalling (Trendelenburg 
et al., 2012).  
 
Conflicting literature exists on the effect of IL-6 on skeletal muscle. IL-6 is a pleiotropic 
cytokine that is secreted and produced by skeletal muscle cells under various conditions 
where it plays an important role in insulin sensitivity and lipolysis (Carey et al., 2006, 
Weigert et al., 2005, Wolsk et al., 2010). It has been shown that IL-6 levels become 
elevated with age and this has been associated with the loss of muscle mass and strength 
(Njemini et al., 2011, Pedersen et al., 2003, Visser et al., 2002). There is evidence to 
suggest that it induces hypertrophy (Serrano et al., 2008) as well as atrophy (Haddad et 
al., 2005). Exogenous IL-6 has been shown to promote myoblast proliferation and 
differentiation (Baeza-Raja and Munoz-Canoves, 2004, Wang et al., 2008). The data 
show that IL-6 has no effect on proliferation and differentiation of either freshly isolated 
or committed human myoblasts. The discrepancies can be attributed wholly to 
differences in doses used and different methodological techniques. The results suggest 
that IL-6 does not affect muscle proliferation or differentiation either at physiological 
(1pg/ml) or supra-physiological (0.1-10ng/ml) doses. Differences in cell extraction and 
digestion, different differentiation medium and different muscle type (vastus lateralis 
muscle vs. temporal muscle) between this study and others (Baeza-Raja and Munoz-






IL-8 belongs to a large family of chemokines that attract primarily neutrophils and act 
as angiogenic factors (Pedersen and Febbraio, 2008). IL-8 mRNA has been shown to be 
enhanced during exercise and IL-8 protein expression within skeletal muscle fibres in 
the recovery from exercise (Akerstrom et al., 2005, Chan et al., 2004).  The 
physiological concentration of IL-1β in serum at rest has been found be 23.9 ± 29.7 
pg/ml in young and 27.6 ± 43.9 in elderly subjects (Kim et al., 2011a). The direct effect 
of IL-8 on muscle cells has not been reported. The present study shows that IL-8 has no 
effect on proliferation and differentiation of human satellite cells, suggesting that IL-8 
has no role to play in muscle cell behaviour.   
 
It must also be stated that the definition of physiological doses for all the cytokines 
studied in the present chapter is based on the concentrations detected in serum. The 
effective concentrations of cytokines to which satellite cells are exposed in skeletal 
muscle tissue have not been determined and may be higher than serum concentrations 
by such mechanisms such as binding to extracellular matrix proteins or localized 
secretion by the myofibres. Other possibilities are that the in vivo effects the cytokines 
examined are modulated by the presence of other molecules that could decrease the 
sensitivity threshold of the cells compared to that observed in vitro, or that the cytokines 
would act cooperatively to exert their effects. Even taking these arguments into 
consideration it is difficult to justify the total absence of any effect over the 1000-fold 
concentration range of IL-6 and IL-8 examined here on the proliferation and 






In conclusion, the data presented herein show that TGF-β1, TNF-α, and IL-1β interfere 
with myogenic progression in a dose dependent manner and suggest that TGF-β1, TNF-
α, and IL-1β might act in vivo to sustain proliferation. Possible mechanisms of action 
include increased cyclin expression with subsequent reductions in cell cycle exit or 
effects on transcription of muscle specific genes. The sustained elevation of these 
cytokines in vivo would result of an inability of satellite cells to regenerate skeletal 

















































Chapter 6: Effects of human 

























6.1 Introduction  
Several studies have undertaken which suggest that muscle extrinsic factors arising 
from the systemic environment may affect muscle repair (Carlson and Faulkner, 1989, 
Carlson and Conboy, 2007, Carlson et al., 2009b). The first experiments to suggest a 
“systemic” impairment to muscle repair and regeneration were performed by Carlson 
and Faulkner (1989) who showed that the mass and function of long term (60 days) 
transplanted rat muscles were impaired by the age of the host, not by the age of the 
transplanted muscle. A parabiotic study has also reported that the systemic environment 
is critical to the success of regeneration by aged satellite cells and suggested that 
inhibitory factors might be present in serum (Conboy et al., 2005). More recently, in 
vitro experiments have demonstrated that sera from elderly rodents or humans inhibit 
myoblast activation and subsequently proliferation and fusion (Brack et al., 2007, 
Carlson and Conboy, 2007, Carlson et al., 2009b). Findings such as these have been 
attributed to reduced serum levels of IGF-1, an imbalance between Notch and TGF-
β/pSmad pathway signalling, and increased levels of circulating TGF-β1 (Carlson et al., 
2009a, Carlson et al., 2008, Reeves et al., 2000). Therefore it seems to be that a loss of 
regenerative potential in the satellite cells depends on the factors present or absent in the 
extra-cellular environment.  
 
Ageing has been associated with increased serum concentrations of inflammatory 
cytokines (Carlson et al., 2009a, Dobbs et al., 1999, Paolisso et al., 1998, Schmitt et al., 
2005, Wei et al., 1992), specifically TGF-β1, TNF-α and IL-6. Experiments in the 
previous chapter showed that TGF-β, TNF-α, and IL-1β robustly inhibit desmin 
expression at early time points in freshly isolated cells. The study presented in this 
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chapter was contributed data to a paper which was published in the Journal of 
Gerontology. 
6.2 Aim 
There were two aims to the study. The first aim was to assess the ability of freshly 
isolated myoblasts extracted from human muscle biopsies to proliferate in culture when 
exposed to serum from either young or elderly subjects. Proliferating muscle cells were 
identified by their expression of the antigens for Ki67 and desmin. The second aim was 
to measure the concentration of inflammatory cytokines in serum that was obtained 
from young and elderly subjects by using Luminex based assays.  
  
6.3 Methods 
The methods for myoblast extraction are detailed in the general methods chapter 
(Section 2.4.1). Methods for human myoblast isolation in human sera are outlined 
below (Section 2.5.1). The protocol for human serum extraction is outlined in the 
general methods chapter (Section 2.3). The Luminex assay was carried out as described 
in general methods chapter (Section 2.9).  
 
6.3.1 Subjects 
Prior to acceptance in the study, participants completed a health questionnaire and were 
only included if they fulfilled the “healthy” or “medically stable” criteria (Greig et al., 
1994). The total sera were collected from 6 young (aged 23-29 years) and 6 elderly 
(aged 69–82 years) subjects and used as specified in the figure legends.  
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6.3.2 Human myoblast cultured in human sera 
A muscle biopsy was obtained from a young male (aged 27 years). Cells were isolated 
and were immediately resuspended in basal medium. Cells were plated in duplicate 
wells of a 24 well plate, coated with ECM matrix (8 mg/ml, Sigma), at a density of 
100,000 cells per well. Growth medium (2X GM, control) or 2Х growth medium 
supplemented with 30% human serum and 2% PSG was then added to each well such 
that final serum and antibiotic concentrations were halved. Media were changed 72 
hours after initial isolation and every 48 hours thereafter. Before discarding, old media 
was transferred to a sterile 1.5ml microcentrifuge tube and centrifuged at 650g for six 
minutes to harvest any floating myoblasts. The supernatant was discarded and the cell 
pellet was re-suspended in fresh medium and added to the appropriate culture wells. 




Statistical comparisons were made using IBM SPSS 19 software, and P values ≤ 0.05 
were considered significant. Statistical significance for interactions between group 
(Young and Elderly) and time was determined using mixed two-way repeated measure 
ANOVA with post-hoc Bonferroni. If there were significant interactions present, 
independent t tests were conducted to confirm statistical significance between variable 
of interest e.g. between groups, and paired-sample t tests undertaken for variable of 
interest within group and time. Results for repeated measure are expressed using the F-




6.5.1 Characterisation of human myoblasts in growth medium 
Typical staining patterns of desmin and Ki67 are shown in Figure 6.1. To determine the 
time course of desmin and Ki67 expression immediately after isolation from muscle 
biopsies, cells were cultured in GM and monitored for three, five and seven days 
(Figure 6.2). Desmin expression was observed in 50% of cells after three days and 85 % 
after seven days (Figure 6.2a). Ki67 expression was observed in 65% at day three and 
90% at day 7 (Figure 6.2b). All desmin positive cells also expressed Ki67 at each time 
point (Figure 6.2c). At day 3 the wells contained an average of 1000 cells indicating that 
1% of plated cells (100000 plated per well) had adhered. At day 5 the wells contained 
an average of 3000 cells and by day 7 the total number was >3000 cells, indicating that 
the number of adherent cells increased with time in culture.   
 
6.5.2 Effects of human serum on freshly isolated cells 
Human myoblasts were cultured in human serum (6 young vs. 6 elderly individuals) and 
monitored for three, five and seven days (Figure 6.3a-c). The number of cells expressing 
desmin, Ki67 and co-staining for both desmin and Ki67 was significantly increased with 
time in culture for all groups, F (2, 9) = 11.122, P = 0.004 for desmin, F (2, 9) = 39.34, P < 
0.0005 for Ki67, F (2, 9) = 21, P < 0.0005 for both desmin and Ki67. No significant 
differences were observed in the percentage of desmin+, Ki67+ and Ki67+desmin+ 
cells at any of the time point examined between young and elderly serum. Figure 6.4a-c 
shows the individual values for desmin and Ki67 co-expression for each serum or for 
GM. High proportions of cells expressing desmin also express Ki67 irrespective of 













Figure 6.1. Images taken from of human myoblasts. Cells from young subject (27 
years) were cultured in the human serum obtained from young (from a male subject 
aged 24 years) (a) and elderly (from a male subject aged 82) (b) subjects. Cells were 
fixed at days 7 and stained for desmin (green), Ki67 (red) and Hoechst 33342 (blue). 
Scale bar = 20 µm. The number of desmin and Ki67 expressing cells was similar 




















































































Figure 6.2. Time course of (a) desmin (b) Ki67 and (c) desmin and Ki67 expression in 












































































Figure 6.3. Time course of (a) desmin (b) Ki67 and (c) desmin and Ki67 expression in 
cells freshly isolated in human serum. Cells were obtained from 27 year old  and 
cultured in media containing serum obtained from young (closed symbols, solid lines, 
n=6, aged 23–29 years) or elderly (open symbols, dashed lines, n=6, aged 69–82 years) 
subjects. Values are mean ± SE. No difference was observed between young and old 
sera conditions. Day 3 is significantly different from days 5 and 7 (* P < 0.0005) for 
desmin and Ki67 expression and significantly different from day 7 only for both desmin 
and Ki67 expression (º P < 0.0005) for both serum conditions. Day 5 is significantly 
different from day 7 for desmin and, both desmin and Ki67 expression (** P = 0.01) for 








































































































Figure 6.4. Individual data points for culture in young serum (YS) or old serum (OS) 
are shown for desmin and Ki67 positive cells at days 3 (1), 5 (b) and 7 (c), blue squares 
indicate responses in GM. Individual serum and gender ages are denoted by the 
following symbols: elderly:  82 yr, □ 69 yr, ▲ 80 yr, △ 77 yr, × 74 yr, ● 82 yr,  
young: ▲ 27 yr, × 24 yr, ○ 23 yr,  24 yr, ● 25 yr, △ 25 yr. 
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6.5.3 Cytokine levels in serum 
There were no statistically significant differences in the serum level of TGF-β1, TNF-α, 
IL-6, IL-8, IL-7, IL-13 and IL-10 between young (n=6) and elderly (n=6) subjects 
(Table 6.1). The level of IL-4 and IL-1β were below the detection limits of the assay 
(0.13 pg/ml) in all young and elderly subjects. Figure 6.5a-g shows the individual 
values for cytokine levels for each serum.  
 
Table 6.1. Serum level of cytokines in young and old subjects. Values are given as 
mean ± SE.  
Cytokine name Serum concentration (pg/ml) 
Young Old 
TGF-β1 1297.0 ± 72.0 1062.0 ± 218.0 
TNF-α 7.0 ± 3.0 5.0 ± 1.0 
IL-6 2.3 ± 0.8 2.0 ± 0.5 
IL-8 4.0 ± 0.3 4.4 ± 0.6 
IL-7 17.0 ± 3.0 18.0 ± 6.0 
IL-13 4.0 ± 2.0 3.0 ± 1.0 
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Figure 6.5. Individual data points for (a) TGF-β1, (b) TNF-α, (c) IL-6 and (d) IL-8 
level in human serum obtained from young (n=6, aged 23–29 years) or elderly (n=6, 
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Figure 6.6. Individual data points for (a) IL-7, (b) IL-13 and (c) IL-10 level in human 






The present study revealed two main findings. Firstly, the proliferation of myoblasts 
was not affected by the age of the circulatory milieu. Secondly, the serum levels of 
TGF-β1, TNF-α, IL-6, IL-8, IL-7, IL-13 and IL-10 showed no significant differences 
between young and elderly individuals.   
 
The system of freshly isolated cells examines the early events of myoblast culture, 
including cell cycle entry. The time course of this response was studied in one cell 
population and observed that sera from both young and elderly subjects was equally 
effective in promoting Ki67 and desmin expression when measured at Days 3, 5 and 7 
(Figure 6.3) of proliferation. In parallel, the time course of Ki67 and desmin expression 
was studied in the absence of human sera (i.e. only in GM, Figure 6.2). Expression of 
both Ki67 and desmin increased with time in culture and virtually all desmin positive 
cells eventually expressed Ki67 showing that myogenic commitment and proliferation 
are closely related at this early stage. It must be noted that this assay cannot determine 
whether the increase in proliferating muscle cells between day 3 and day 5 is due to 
increased desmin expression in proliferating cells, increased proliferation in desmin 
positive cells or more robust proliferation of the cells which were double labelled at day 
3. 
 
In this study serum concentration from young and elderly subjects was measured by a 
Luminex based assay. No differences were seen in the levels of TGF-β1, TNF-α, IL-6, 
IL-8, IL-7, IL-13 and IL-10 between the two groups. This could then explain why the 
cells behave the same in young and elderly serum. Some controversy surrounds the 
cytokine levels with age, as some studies demonstrated no age related difference (Bayer 
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et al., 2012, Kim et al., 2011a, Pedersen et al., 2004), while others found an increased in 
elderly subjects when compared to young subjects (Carlson et al., 2009a, Ferrucci et al., 
2005, Zhu et al., 2009). A likely reason for such a discrepancy is that in the latter 
studies the participants were not pre-screened for confounding medical conditions, 
which could increase inflammation. In contrast, the subjects used in the present study 
and those by (Kim et al., 2011a, Pedersen et al., 2004) were generally healthy. Although 
this study is based on more subjects than any previous studies, the variation between 
individuals potentially impact on outcomes. That said, the fact that there were no 
differences despite there being heterogeneity between individuals, suggests that if there 
were any age related differences, a large number of cell populations would need to have 
been studied to demonstrate this statistically. Whilst this possibility cannot be excluded 
the data presented here suggest that that there are no age related differences.  
 
It was shown that TGF-β1 inhibits the proliferation and differentiation of skeletal 
muscle cells in vitro (Figure 5.2 & 5.8 in Chapter 5). Recent reports demonstrated that 
skeletal muscle satellite cells cultured in young and elderly serum are highly sensitive to 
TGF-β1 (Carlson et al., 2009a, Carlson et al., 2009b). The present thesis shows that 
there is no significant difference in TGF-β1 levels between the sera of young and old 
subjects (1297 ± 72 pg/ml vs. 1062 ± 218 pg/ml) and these concentrations should be 
inhibitory (Figure 5.2 & 5.8 in Chapter 5). TGF-β1 is secreted in latent forms in a large 
latent complex which is attached to the extracellular matrix and release of TGF-β from 
this complex is required to allow receptor binding and initiation of the desired signalling 
pathway and subsequent response (O'Kane and Ferguson, 1997, Munger et al., 1997, 
Gleizes et al., 1997). There is no conclusive evidence to demonstrate whether TGF-β1 is 
active or not active in human serum. Taken together these results suggest that serum 
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TGF-β1 levels are not active. Specifically, “if all endogenous young and old sera TGF-
β1 were active, it would readily suppress satellite cell proliferation in vitro” (Carlson et 
al., 2009a).  
 
There are various differences in the findings between this study and other recent studies. 
The findings in this study showed that muscle proliferation and differentiation is not 
impaired with age. In contrast to the data herein, it has previously been demonstrated 
from studies in mice and humans that serum from aged individuals decreases the ability 
of myoblasts to proliferate, or express the muscle markers, Pax7, Myf5, MyoD, and 
desmin (Brack et al., 2007, Carlson and Conboy, 2007, Carlson et al., 2009b). Whilst 
the difference between this study and those using a mouse cell /serum model (Brack et 
al., 2007, Carlson and Conboy, 2007) would not be the first instance of a species 
difference, there are some methodological differences between the protocol used in this 
study and that used by Carlson and Conboy (2007) and Carlson et al. (2009b). Most 
significantly, the cells used for most mouse cultures were associated with living 
myofibres when isolated from tissue. The mouse muscle was also severely injured two 
days prior to myofibre extraction (Carlson and Conboy, 2007), thus the satellite cells 
were already activated in vivo. The biopsy in this study was obtained from resting 
muscles and the cells are only activated during the biopsy and cell preparation 
procedures. The human myoblast isolation procedures outlined in this study are 
comparable with those of many laboratories (Dellavalle et al., 2007, Schafer et al., 
2006). Other methodological differences between this study and other experiments 
(Brack et al., 2007, Carlson and Conboy, 2007, Carlson et al., 2009b) include the use of 
different enzymes for tissue digestion (trypsin as opposed to collagenase), the use of 
different markers to measure cell proliferation (Ki67 as opposed to BrdU), different 
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time points for initial measurements (72 versus 48 h), different serum concentrations 
(15% versus 10%) and the fact that the sera were not pooled by age group in any of the 
present assays. Pooling of serum may represent the major source of difference in 
observations presented here and in (Carlson et al., 2009b), which eliminating the 
possibility for comparison between individual serum donors. It must be noted that 
individual serum samples were used in this study. Further work is needed to clarify 
what effects these methodological differences may have. However, the results would 
suggest that the source of any age related inhibition of satellite cell response is not 
serum borne. 
 
Whilst there are data showing impaired satellite cell behaviour (Brack et al., 2007, 
Carlson and Conboy, 2007, Conboy et al., 2005), it is noteworthy that there are a 
number of other studies which suggest that satellite cell proliferation and myogensis 
occur as effectively in older as in young animals. For example, recent work examining 
whole muscle grafts transplanted between young (8 weeks) and old (13-21 months) 
mice suggest that there are minor age-associated delays in inflammation and 
neovascularisation in response to injured muscle with no detrimental effect on muscle 
regeneration (Smythe et al., 2008). Other animal studies which have used a variety of 
different models including chronic low-frequency electrical stimulation (Putman et al., 
2001), denervation (Dedkov et al., 2003) as well as cross transplantation in mdx mice 
(Boldrin et al., 2009) have similarly observed no age related impairment to muscle 
repair. Taking the above observations into account, it is also possible to speculate that 
there is a slower activation of young cells cultured in old serum that might be detectable 
before day three of culture, but the data presented show that even if this were the case, 
these initial differences have no effect on later myogenic responses. 
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In human exercise studies there is also some debate as to whether there is an age related 
impairment to the function of satellite cells. There is some evidence that in response to 
an acute bout of exercise, the increase in satellite cell number may be blunted in older 
male individuals (Dreyer et al., 2006). Furthermore, a short period (4 weeks) of strength 
training immediately following a two weeks period of cast immobilization, resulted in a 
blunted satellite cell response in the older muscles (Carlson et al., 2009b).  These short 
term responses seem in contrast to the results of a number of longer (12-16 weeks) 
strength training studies, which suggest that satellite cell number can be successfully 
increased in older individuals (Mackey et al., 2007, Roth et al., 2001, Verdijk et al., 
2009, Verney et al., 2008) with no age related impairments (Roth et al., 2001). These 
data coupled with the demonstrated effectiveness of strength training regimens to 
increase muscle mass and improve function, even in very elderly people (Fiatarone et 
al., 1990, Harridge et al., 1999).   
 
Taken altogether the literature has a body of work which suggests that age-related 
impairments in satellite cell mediated repair exist in animal muscles following severe 
damage. There are no equivalent human models for such extreme damage. There is also 
emerging evidence in animals suggesting that there is no age-related impairment but 
suggesting that there may be delayed response. The results of this study suggest that 
there is no effect of the aged circulatory milieu on the behaviour of freshly isolated 















































7.1 Main findings 
The data presented in this thesis demonstrated no difference in the behaviour of cells 
obtained from both either young or elderly people at least in terms of the parameters 
measured which related to proliferation and differentiation. However, dramatic 
differences were observed in cells that had undergone replicative senescence. A marked 
reduction in differentiation potential was observed in the senescent cells, as evidenced 
by a decrease in the expression levels of myogenin after three days of differentiation 
and MHC after five days of differentiation. In addition, senescent cells exhibited higher 
expression of the DNA damage marker γ-H2AX and increased TGF-β secretion 
(Chapter 3 and 4). The work presented in this thesis also indicated that TGF-β1, TNF-α, 
and IL-1β interfere with myogenic behaviour in a dose dependent manner (Chapter 5), 
but that young and healthy elderly sera contain similar amounts of these cytokines and 
thus seemed equally effective in promoting proliferation and desmin expression in 
human myoblasts independent of the age of the subject (Chapter 6). 
 
7.2 Intrinsic behaviour of human myoblasts 
Replicative senescence of cells in culture has previously been used as a model to study 
the ageing process in human muscle (Bigot et al., 2008). However, the relevance of this 
approach to in vivo ageing remains unclear. Chapter 3 and 4 are the first study to 
investigate whether in vivo muscle ageing differs from in vitro muscle ageing by 
studying primary human muscle cells obtained from both young and elderly people, 
before and after they reached replicative senescence. Several parameters associated with 
ageing process were compared: ability to undergo differentiation; presence of DNA 
damage; and production of cytokines. The progression of differentiation of human 
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primary myoblasts was shown to be decreased and delayed by two-four days in 
senescent compared to early passage cells. However, the differentiation rates of cells 
from older subjects were similar to those of cells from young subjects at early passages 
and did not exhibit the characteristics of the senescent cell populations. Only the 
senescent cells demonstrated altered cell morphology, exhibited significant DNA 
damage and high levels of TGF-β1 and IL-8 secretion. These data suggest that passage 
number is a critical factor to control in such experiments as reductions in differentiation 
potential is significantly affected after sixteen days of “in vitro ageing”. This important 
as a number of human myoblast studies involve a cell expansion period of indeterminate 
duration (Beccafico et al., 2007, Beccafico et al., 2010, Corbu et al., 2010, Fulle et al., 
2005, Lorenzon et al., 2004, Pietrangelo et al., 2009).  
 
The data reported in Chapter 4 show that senescent cells secrete high concentrations of 
TGF-β1 (250-300 pg/ml) and this concentration inhibits myoblast fusion. It could thus 
be suggested that delay and decrease differentiation in senescent myoblasts is 
determined by TGF-β1 production since by day 3-5 myogenin and MHC expression is 
such that it corresponds with a reduction in TGF-β1 secretion to 100pg/ml, a non 
inhibitory concentration.   
 
The major question is whether the changes observed in replicative senescence reflect in 
vivo ageing. Many studies on human fibroblasts have demonstrated an inverse 
relationship between donor age and replicative lifespan (Macieira-Coelho and Ponten, 
1969, Schneider and Mitsui, 1976). This effect is inconsistent with a high number of 
health donor samples (Cristofalo et al., 1998). The work in this thesis and that of others 
did not discern any correlation between the age of the donor and the number of mean 
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population doublings before myoblasts senesced (Decary et al., 1997, Mouly et al., 
2005, Pietrangelo et al., 2009, Renault et al., 2000). It has also been shown that 
myoblasts extracted from elderly biopsies (>80 years) behave similarly to those 
obtained from very young cell populations (2-5 years) in terms of their mean population 
doublings (Schafer et al., 2006). One explanation that has been proposed for the contrast 
in behaviour between myoblasts and skin fibroblasts is that satellite cells in healthy 
muscle would not normally undergo a significant number of divisions in vivo once 
growth has ceased and therefore would maintain their proliferative potential throughout 
the lifespan of the individual (Decary et al., 1997). A similar maintenance of 
differentiation capacity would also be coherent with this explanation. 
 
The data reported in Chapter 3 show a large heterogeneity in proliferation capacity and 
desmin content of myoblasts obtained from different subjects, even when these are of 
the same age group. In this regard Schafer et al. (2006) found that the number of 
population doublings and proportion of desmin expression in human myoblasts varies 
independently of age. There also does not appear to be a relationship between myogenic 
purity (proportion of desmin positive cells) of a population and the age of the donor 
(Beccafico et al., 2007, Pietrangelo et al., 2009, Schafer et al., 2006).  
 
Two key differences were noted between the work in this thesis and those who 
identified age related impairment of human myoblast differentiation: 
i. Some studies draw conclusions from comparisons of very small numbers of 
subjects, often only one from each age group (Fulle et al., 2005, Jacquemin et 
al., 2004, Lorenzon et al., 2004).  
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ii. Other studies draw conclusions from comparing populations that do not have 
equivalent proportions of cells expressing desmin (Beccafico et al., 2007, 
Pietrangelo et al., 2009) or have not been characterised in terms of desmin 
content (Beccafico et al., 2010).  
 
Desmin content reflects the proportion of myogenic cells in the culture and therefore 
determines differentiation potential of a population independently of age. Studies 
comparing only one subject from each age group do not provide strong enough evidence 
on their own of age related effects, since in the human population there are very large 
variations in factors other than age (i.e. genetic and lifestyle factors) that could provide 
an explanation for the effects observed. 
 
As mentioned above, the data show that proliferation and differentiation of human 
myoblasts are not affected by the age of the donor. Supporting evidence for the above 
include recent in vitro experiments with myoblasts from elderly animals showing that 
these can proliferate and differentiate similar to that of young animals (Dumke and 
Lees, 2011). Furthermore, it has been shown that human myoblasts from an elderly 
donor can contribute myonuclei very efficiently to regenerating mouse muscle in vivo 
(Schafer et al., 2006). Collins et al. (2007) found that elderly mouse satellite cells are 





7.3 Behaviour of human myoblasts in the presence of cytokines 
Circulating levels of IL-6, TNF-α and TGF-β seem to increase with advancing age 
(Carlson et al., 2009a, Dobbs et al., 1999, Njemini et al., 2011, Paolisso et al., 1998, 
Wei et al., 1992). Local production of TGF-β, TNF-α and IL-1β also increase in aged 
skeletal muscle (Leger et al., 2008, Przybyla et al., 2006, Carlson et al., 2009b). The 
exact effect of these cytokines on skeletal muscle satellite cells is not clear and the 
results from different studies are contradictory (Table 5.1). However, the concentrations 
of cytokines administered differ between studies with the majority only assessing the 
effect of one concentration of cytokine on myoblasts. In Chapter 5, a comprehensive 
characterization of the dose-dependent effects of IL-6, IL-8, IL-1β, TNF-α, and TGF-β 
was tested on human myoblasts proliferation and differentiation. The data show that 
TGF-β1, TNF-α, and IL-1β are potent inhibitors of desmin and myogenin expression in 
freshly isolated primary muscle cells during the early stage of activation. Cell 
proliferation was not impaired as evidenced by the expression of Ki67, but commitment 
to the myogenic lineage was suspended (as evidenced by impaired desmin expression) 
even though the cells were expressing the satellite cell marker NCAM. Importantly, 
inhibition of desmin expression in freshly isolated myoblasts was reversible after 
removal of TGF-β1, TNF-α, and IL-1β from the medium. In committed myoblasts these 
cytokines do not inhibit desmin but do inhibit differentiation as indicated by decreased 
myogenin expression. Taken together the data suggest the cytokines have no effect on 
proliferation of myoblasts, but do inhibit progression of both myogenic commitment 
and differentiation. The three cytokines may act through similar mechanisms to exert 
their effect. Although not tested in the present thesis this may indicate that the cytokines 
could inhibit cell cycle withdrawal and therefore reduce differentiation. Thus sustained 
elevation of these cytokines would seem to result of in an inability of satellite cells to 
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regenerate skeletal muscle after damage. Interestingly, the cytokines IL-6 and IL-8 have 
no effect on proliferation and differentiation of human satellite cells, suggesting that IL-
8 and IL-6 may have no role to play in muscle repair.   
 
7.4 Behaviour of human myoblasts in the presence of human serum 
Freshly isolated cells cultured in media containing human sera to examine the onset and 
progression of Ki67 and desmin expression showed no effect of the age of the serum 
measured at 3, 5 and 7 days of proliferation. The results suggest that human myoblast 
behaviour is not negatively affected by culture in an “elderly environment”. This might 
be explained by the fact that serum levels of TGF-β, TNF-α, IL-6, IL-8, IL-7, IL-13 and 
IL-10 were found to be similar between young and healthy elderly subjects.  
 
This thesis shows that TGF-β1 inhibits the proliferation and differentiation of skeletal 
muscle cells in vitro even at low concentrations (300 pg/ml; Figure 5.2, 5.8, 5.12 & 5.15 
in Chapter 5) and as mentioned above there is no significant difference in TGF-β1 
levels between the sera of young and old subjects. However, these concentrations (1297 
± 72 pg/ml vs. 1062 ± 218 pg/ml)  should be inhibitory (Figure 5.2 & 5.8 in Chapter 5). 
Importantly, there is no conclusive evidence to demonstrate whether TGF-β1 is active 
or not active in human serum because TGF-β1 is secreted in latent forms in a large 
latent complex which is attached to the extracellular matrix and release of TGF-β from 
this complex is required to allow receptor binding and initiation of the desired signalling 
pathway and subsequent response (O'Kane and Ferguson, 1997, Munger et al., 1997, 
Gleizes et al., 1997). Taken together these results might suggest that serum TGF-β1 
levels are not active. Specifically, “if all endogenous young and old sera TGF-β1 were 
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active, it would readily suppress satellite cell proliferation in vitro” (Carlson et al., 
2009a).  
 
The data in this thesis on freshly isolated cell cultures are in contrast with results from 
studies in mice (Brack et al., 2007, Carlson and Conboy, 2007) and humans (Carlson et 
al., 2009b) where serum from elderly donors decreased the ability of myoblasts to 
incorporate BrdU and express the muscle markers, Pax7, Myf5, MyoD, and desmin. 
 
Three key differences were noted between the in vitro myoblasts experiments 
performed by Brack et al. (2007), Carlson and Conboy (2007) and Carlson et al. (2009) 
and the human protocol used in this thesis:  
  
i. The mouse muscle tissue was severely damaged two days prior to satellite cell 
extraction, thus the satellite cells were already activated in vivo prior to their 
culture in vitro. There are no equivalent human models for such extreme 
damage. Biopsies were obtained from resting muscles and satellite cells were 
only activated during the biopsy and cell preparation procedures.  
ii. Satellite cells in the mouse experiments were cultured with their associated 
myofibres intact. It was not possible to include whole human fibres in the 
established culture protocol.  
iii. Pooling of serum may represent the major source of difference in observations 
presented here and compared with Carlson et al. (2009) since one or two badly 
performing sera would “contaminate” the whole batch suggesting that there is a 
difference between young and elderly subjects when in fact only one or two 
outliers may show  a diminished response.  
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Satellite cells behaviour in vivo is moderated by its myofibre and basal lamina as well as 
neuronal factors, cell-cell interaction with fibroblasts and adipocytes and other factor 
within the “niche” (Gopinath and Rando, 2008). Whilst studying the behaviour of cells 
in culture has a number of experimental advantages, the extent to which their behaviour 
in culture can be extrapolated to behaviour in vivo remains unclear. The precise 
composition of the satellite cell niche in vivo is likely to be only estimated crudely by 
culture conditions. It is possible that satellite cell niche may not have been accurately 
recreated in this study which could be a contributing factor to the lack of response 
noted.   
 
Satellite cells can be identified in cryosections of human muscle biopsy samples and a 
number of studies have demonstrated that satellite cell number can be increased in 
elderly people following a period of strength training (Mackey et al., 2007, Roth et al., 
2001, Verdijk et al., 2009, Verney et al., 2008). In those studies that had a comparable 
group of young subjects, no age related differences in satellite cell number have been 
reported (Roth et al., 2001). These data coupled with the demonstrated effectiveness of 
strength training regimens to increase muscle mass and improve function, even in very 
elderly people (Fiatarone et al., 1990, Harridge et al., 1999), suggest that satellite cell 
behaviour, in the longer term is not limiting muscle adaptation to normal resistance 
exercise training in later life. 
 
Finally, it must be noted that following enzymatic digestion and isolation of satellite 
cells, it is possible that only “good” cells were isolated from the elderly biopsies and 
that in vivo “bad” cells might be poorly functioning. However, given the similarity in 
yield between young and old biopsies this seems unlikely.  
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In conclusion, the data in this thesis show that whilst a senescent phenotype can be 
readily obtained in vitro, the behaviour of early passage cells in regard to the 
characteristics relevant for muscle regeneration (proliferation and differentiation) are 
similar between cells obtained from young and elderly people. This coupled with other 
evidence, suggests that the satellite cells in vivo are functional in later life and may not 
be critically involved in the mechanism responsible for sarcopenia. However, their 
sensitivity to inflammatory cytokines suggests that if these were present in vivo from 
other tissues (myofibres, connective tissue, nervous tissue) they might affect the 
myogenic behaviour of the cells. 
 
7.5 Future direction 
The results of the work presented in this thesis raise a number of possibilities for future 
research. These include: 
I. Marked heterogeneity in desmin content was found in myoblasts obtained from 
different subjects, several populations of cells maintained their initial desmin 
content whereas others lost their desmin content over time in culture. It is 
possible that the balance of fast proliferating to slow proliferating muscle 
precursor cells may ultimately determine culture purity in the presence of 
contaminating fibroblasts. Fast proliferating cells may outstrip the growth of 
fibroblasts, or whereas slow proliferating may be outgrown by them. 
Nevertheless, it will be important for future work to enrich cultures with 
myogenic cells and eliminate fibroblasts and other non-myogenic cells using a 
separation technique (Magnetic sorting). 
II. This thesis showed that proliferative potential, differentiation potential and 
differentiation time course were similar between cells from the young and 
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elderly subjects at the earliest passage analysed. When the cells reached 
senescence, expression of myogenin and MHC was delayed by two-four days 
following transfer to differentiation medium when compared to early passage 
cells. To confirm no ageing effect gene expression profiles of human myoblasts 
and telomere length should be analysed to determine if these differ when 
comparing ageing in vivo to replicative senescence of human myoblasts in vitro.  
III. The work presented in this thesis indicated that TGF-β1, TNF-α, and IL-1β 
interfere with myogenic behaviour in a dose dependent manner and this effect 
was reversible. The next step would be to study the signalling pathways 
involved to determine the interaction between TGF-β1, TNF-α, and IL-1β which 
affect skeletal muscle. The length of time over which treatment with these 
cytokines can maintain this immature state and still be fully reversible, without 
affecting the proliferation or differentiation potential, of the myoblasts also 
remains to be determined. Furthermore, it might be important for future work to 
inhibit TGF-β1, TNF-α, and IL-1β to determine the effect on human myoblasts 
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